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INTRODUCTION

Osteogenesis imperfecta (OI) is a heterogeneous genetic
disease which has been characterized by extremely fragile
bones and other connective tissue abnormalities (Sillence et
al., 1979a, 1979b; Prockop, 1984). Molecular defects in the
Type

I

collagen genes which affect

the

synthesis

and/ or

structure of the collagen protein are involved in many cases
of OI (Prockop et al., 1989; Byers, 1989; Cole et al., 1989).
Most of these mutations alter the repeated Gly-X-Y amino acid
sequence

in

the

triple

helical

domain,

leading

to

the

formation of an unstable helix which compromises the tensile
strength of mature collagen fibrils (Pope et al., 1989).
The

severity

of

the

OI

symptoms

vary

considerably

between individuals and no two cases have been found to have
exactly the same molecular defect. In cases where individuals
have similar mutations their phenotypes can vary greatly
(Pope et al., 1985). Furthermore, there are instances where
multiple asymptomatic members of a

family carry the same

defect as the affected individual

(Superti-Furga et al.,

1989; Sykes et al., 1990). In some cases of OI, particularly
the progressively deforming moderately severe form of the
disease, or OI Type III, no apparent Type I collagen defects
have been found

(Byers et al.,

1987;

Aitchison et al.,

2

1988).

Thus, there are clearly additional genes involved in

contributing

to

the OI

phenotype

other

than

the Type

I

collagen genes.
Previous studies have shown that a pro-a2(I)
complementary

DNA

(cDNA)

probe

detects

two

undescribed sites in collagen-like gene (s)

previously-

other than the

already characterized f ibrillar collagen genes
al.,

collagen

(Doering et

1990). Deletions at the two sites are found to occur

much more frequently in OI Type III patients than in normal
individuals.

At

both

sites

the

deletions

occur

in

a

spontaneous fashion and are of heterogeneous size (Doering et
al., 1987). Site 1 is detected in normal individuals as a 7.4
kb HindIII restriction fragment which completely contains a
3.0 kb PstI fragment. Site 2 is detected as a 4.6 kb HindIII
fragment in normal individuals which overlaps with a 5.2 kb
PstI

fragment.

Site

2

has

recently

been

localized

to

chromosome 17 (Cammarata et al., 1991).
This

thesis

describes

the

isolation

and

characterization of Site 2, specifically the 4.6 kb HindIII
fragment. The cloning, mapping and sequencing of its triple
helical coding regions are described. Sequence comparisons to
known collagen genes, as well as other non-collagenous genes,
are made in an effort to further characterize this gene and
gain insight to its function. This sequence information will
help to identify the structure of the putative collagen-like
protein which the

sequence encodes

and thus

suggest how

3

abnormalities
phenotype.

in this protein could contribute to the OI

LITERATURE REVIEW

OI and Type I Collagen
Osteogenesis

imperf ecta

is

one

of

the

most

common

connective tissue disorders and occurs in approximately 1 in
5,000 to 10,000 individuals

(Byers and Steiner,

1992).

In

addition to fragile bones which fracture under minimal stress,
other

symptoms

occur

to

dentinogenesis imperfecta,

a

varying

thin skin,

degree,

including

joint hypermobility,

blue sclerae and hearing impairment (Sillence, 1988; Byers,
1989). All of the affected tissues are rich in Type I collagen
and many, but not all, OI cases are associated with defects
in one of the two Type I

collagen genes,

COLlAl or COL1A2

(Byers et al., 1984; Cohn et al., 1988; Bateman et al., 1988).
In approximately 85% of those affected with OI, a dominant
mutation

in

one

of

the

two

structural

genes

for

Type

I

collagen is present (Wenstrup et al. 1990).
Collagen

is

the

major

structural

extracellular matrix or ECM (Kuhn, 1987).

component

of

the

Type I collagen

accounts for about half the dry weight of bone and over 80%
of the dry weight of skin, tendons and ligaments (Prockop and
Kivvirko, 1984). It is a heterotrimer composed of two al and
one a2 polypeptide chains, designated pro-al(I) and pro-a2(I)
4

5

respectively. The two individual chains are coded for by the
well-characterized genes COLlAl and COL1A2, respectively (Chu
et al., 1985a; Myers et al., 1983; de Wet et al., 1987). Both
chains are synthesized as procollagen precurser molecules,
consisting of a central triple helical region made up of a
repeated Gly-X-Y amino acid sequence and flanking propeptide
regions at the carboxy and amino termini.

Collagen Assembly
Triple-helix formation begins with the aid of sequences
at the carboxy end of the chains and proceeds in a zipper-like
fashion toward the amino terminus. The small glycine residue
in every third position of the central molecule facilitates
the folding of the three chains into a characteristic triple
helical

configuration

polypeptide chains.

allowing

tight

association

of

the

Pro line and lysine residues are often

present in the X and Y positions of the repeat. During helix
assembly

these residues

are hydroxylated and some prolyl

residues are further glycosylated.

This post-translational

modification is important for helix stability and continues
until

triple helix

formation

is

complete

(Prockop,

1984;

Byers, 1989; Byers et al., 1987). Therefore, the extent of
modification is dependent upon the rate of helix formation
(Bateman et al., 1988).
Upon

completion

of

helix

formation

the

procollagen

molecule is secreted into the ECM and its carboxy and amino

6

propeptide regions are cleaved,

leaving a mature collagen

triple helix with short telopeptides at both ends (Prockop et
al., 1989). Within the ECM multiple collagen polypeptides are
arranged

end

crosslinked

on
in

end,
a

stacked

quarter

in

a

parallel

staggered

fashion

array

of

and

collagen

microfibrils (Bruns and Gross, 1974; Prockop, 1984). Thus, a
compact and rigid triple helix is essential for the tensile
strength of mature collagen fibers (Byers et al., 1987; Byers
1989). The propeptide sequences at the carboxy and amino ends
are important in chain alignment and secretion of the mature
collagen molecules into the extracellular matrix (Sandell and
Boyd, 1990; Prockop et al., 1989; Byers et al., 1987). The
non-helical telopeptides represent sites where

inter- and

intra-molecular crosslinking occurs in the mature molecule via
disulfide

bonding

between

cysteine

residues.

Both

the

appropriate post-translational modification and intermolecular
crosslinking

are

important

in

stabilizing

the

molecular

arrangement within collagen molecules and between resultant
fibrils, affording them thermal stability at body temperatures
(Kuivaniemi et al., 1991).
Because the extent of post-translational modification is
dependent upon the rate of helix formation, mutations in the
Type I collagen genes which result in a decrease in the rate
of triple helix formation often result in

overmodif ication

(Bateman et al.,

1985).

interfere

with

1986; Bonadio and Byers,
the

folding,

processing

and

This can

formation

of

7

thermally stable collagen molecules. Those unstable molecules
are often rapidly degraded resulting in the production of
reduced amounts of collagen.

Type I Collagen Defects in OI
Many

different

kinds

of

Type

I

collagen

defects

associated with OI have been described. Two general classes
of mutations have been obeserved: mutations which affect only
the amount of Type I collagen produced (Barsh & Byers, 1981)
and mutations that alter the structure of the Type I collagen
chains.

The

mildest

forms

of

OI

generally

decreased collagen production due to

a

result

from

non-functional or

partially functional allele (Prockop et al., 1989). The more
severe phenotypes result from the secretion of structurally
defective,

overmodified

procollagen

chains

that

are

incorportated into mature collagen molecules. Subsequently,
these interfere with the self-assembly of fibrils (Cohn and
Byers, 1991; Kuivaniemi, et al., 1991).
The
fibril
growth.

system

of

collagen

biosynthesis

and

subsequent

formation depends upon the principle of nucleated
such systems begin with a few subunits forming a core

nucleus that is then self-propagated to generate a
structure.

This

kind

of

system

is

highly

larger

vulnerable

to

mutations that cause the synthesis of structurally defective
but partially functional molecules. In bone, collagen fibrils
are

very

densely

packed.

If

an

abnormal

molecule

is

8

incorporated into the fibril the uniform environment which
contributes to tissue strength is compromised.

Not only is

that molecule less stable, but adjacent molecules are also
affected.

It is also possible that the fibrils which have

incorporated abnormal molecules may not be mineralized as
efficiently

(Byers,

1990).

It is not suprising then,

that

production of structurally defective molecules would cause a
more severe phenotype. Thus, in terms of clinical symptoms,
it is less detrimental to produce fewer normal collagen chains
than to incorporate large numbers of defective ones.
Among the most commonly studied gene defects in OI are
point mutations which cause a codon change, most commonly a
substitution for a Gly residue (Cohn et al., 1990, Wallis et
al.,

1990;

Cole et al.,

1992) .

These substitutions often

result in the disruption of the triplet pattern or cause
incorrect exon splicing (Tromp and Prockop, 1988). Deletions
can also cause splicing defects
Tromp

and

Prockop,

1988)

or

(Kuivaniemi et al.,

missing

coding

Occasionally insertions have been observed

1988;

information.

(Byers et al. ,

1988b; Genovese et al., 1989) and sometimes small insertions
or deletions are responsible for frameshift mutations (Willing
et al.,

1990;

Bateman et al.,

1989;

Pihlajaniemi et al.,

1984).

Types of OI
The

severity

of

this

disease

varies

greatly

from

9

individual to individual with regard to frequency of fractures
as well as the extent to which the other symptoms are present
(Superti-Furga, 1989). Its heterogeneity is reflected at both
the clinical and molecular levels but its classification into
one

of

four

types

is

based

mainly

on

clinical

symptoms

(Sillence, 1979a; Sillence, 1988; Byers et al., 1987; Prockop,
1984). Most research at the molecular level has focused on
cases of OI where Type I collagen defects are found.
Severe perinatal lethal OI, or OI Type II, is the best
studied form of the disease. It is characterized by neonatal
dwarfism, multiple fractures leading to severe bone deformity,
and

results

(Sillence,

in

death

in

utero

or

shortly

after

birth

1988). It is usually the result of new dominant

mutations and involves heterogeneous defects in one of the
Type I collagen genes which primarily disrupt helix formation
(Byers et al., 1988a; Byers et al., 1988b). For example, point
mutations which cause a glycine residue to be replaced by a
bulkier residue in the triple helical portions of the collagen
molecule not only alter the repeated Gly-X-Y pattern, slowing
helix formation,

but also result in poor secretion of the

overmodified, thermally unstable procollagen molecule into the
extracellular matrix
1988).

(Cohn et al.,

1988;

Willing et al.,

Those structurally defective molecules, with varying

degrees of thermal stability, which do get secreted are then
incorporated into the microf ibril and have consequences for
the nucleated growth of mature

fibrils.

For example,

one

10
lethal variant with a cysteine for glycine substitution in the
al(I) chain did not prevent the folding of the triple helix,
but instead it introduced a "flexible kink" in the helix. This
delayed fibril formation, reduced the total amount of collagen
incorporated into the fibrils,

and drastically changed the

morphology of the fibrils (Prockop et al., 1989).
The substituted residue in Type II OI cases is often
cysteine or arginine
1987)

(Vogel et al. ,

but substitutions by valine

1987; Bateman et al.,
(Lamande et al.,

1989;

Patterson et al., 1989), serine (Lamande et al., 1989) and
aspartate (Baldwin et al., 1989) have also been described.
Other mutations

such

as

deletions

in

the

helical

coding

regions of the Type I collagen genes (Barsh et al., 1985; Chu
et al., 1985b; Willing et al, 1988) and point mutations which
lead to splicing defects causing missing exons

(Tromp and

Prockop, 1988) have also been described. Additionally, some
recurring cases of Type II OI, originally thought to be due
to autosomal recessive inheritance, can be accounted for by
germ line mosaicism in one parent (Byers et al., 1988a; Cohn
et al., 1990; Constantinou et al., 1990; Wallis et al., 1990).
The mild dominantly inherited form of OI, or Type I, also
involves defects in the structure and/or synthesis of Type I
collagen.

It

is

characterized

by

bone

fragility

which

decreases at puberty, short stature, blue sclerae, deafness
and sometimes dentinogenesis imperfecta (Sillence, 1988). In
a number of studies the phenotype has been shown, by analysis

11
of

restriction

fragment

length

polymorphisms

(RFLP),

to

consistently segregate with one or the other of the Type I
collagen genes (Sykes et al., 1986; Tsipouras et al., 1984;
Falk et al., 1986). Thus, defects in Type I collagen genes are
clearly responsible for the OI Type I
cases however,

phenotype.

In these

the triple helix is as thermally stable as

normal collagen,

or only slightly unstable,

but the total

amount of collagen secreted is lower than normal (Rowe et al.,
1985; Bateman et al.,

1989; Byers et al.,

1988a).

In some

cases, it has been suggested that point mutations which cause
substitutions in the X or Y positions of the repeat rather
than in the glycine position, as is seen in Type II cases, are
responsible for greater thermal stability and perhaps the
milder phenotype (Bateman et al., 1988). More recently it has
been shown that one of the Type I collagen gene alleles is
silent, or non-functional, resulting in production of reduced
collagen amounts (Willing et. al, 1992).
The more severe dominantly inherited form of OI, or Type
IV also involves a variety of Type I collagen defects.
characterized

by

moderate

deformity of long bones and,

clinical

severity,

It is

variable

in contrast to OI Type I, the

sclerae of these individuals are pale blue or white (Sillence,
1988). RFLP analysis has shown that in many cases this form
of the disease segregates with the COL1A2 gene (Superti-Furga
et al., 1989; Sykes et al., 1990). Glycine substitutions in
the triple helical domain of the pro-a2(I) chain are, in fact,

12

associated with many Type IV cases (Wenstrup et al.,

1986;

Wenstrup et al., 1988). These substitutions are often located
in an analogous position in the helix to those al(I) chain
substitutions in Type II OI cases, yet they result in the nonlethal Type IV condition (Cohn and byers, 1991; Superti-Furga
et al., 1989).
The progressively deforming, moderately severe form, or
OI Type III is one of the most common types of OI and the
least well-characterized with respect to molecular defects.
Its progressive nature is due to repeated multiple fractures
leading to severe deformity of the limbs and spine (Sillence,
1988). Most cases are due to spontaneously-occurring dominant
mutations

while

a

few

consanguinous parents are

are

autosomal

involved.

recessive,

when

(Pihlajaniemi et al.,

1984; Bonadio et al., 1990a). There have been some reports of
substitutions and deletions in the Type I collagen genes of
OI Type III patients

(Bateman et al.,

1988; Byers et al.,

1988a; Pack et al., 1989; Byers 1983; Pihlajaniemi et al.,
1984), but there are many cases where no such defects have
been found (Byers et al, 1987; Byers et al., 1988a; Steinman
et al., 1988; Beighton et al., 1988; Wenstrup et al., 1990).
The variability of the clinical symptoms within this form of
OI suggests further genetic heterogeneity within the group.
RFLP analysis of several of the recessive pedigrees for Type
III OI have shown that this form of OI is often unlinked to
either of the Type I

collagen genes

(Byers et al.,

1987;

13

Aitchison et al., 1988).
It

has

been

suggested

that

for

those

cases

where

mutations in the Type I collagen genes have been excluded,
defects in other ECM genes could be responsible for expression
of

the

OI

phenotype.

Other

genes

encoding

bone-specific

proteins which may interact with Type I collagen, are likely
candidates (Byers, 1990).

OI Heterogeneity: A Potentially Polygenic Disease
Although large numbers of OI cases have been studied at
the molecular level there is still very little understanding
of how the specific defects in Type I collagen contribute to
the OI
specific

phenotype.
kinds

It has

of

not been possible to correlate

molecular

defects

with

particular

OI

phenotypes. The different forms of the disease cannot always
be

distinguished

by which

of

the

Type

I

collagen genes

contains the defect nor can they always be associated with the
location of the defect within certain domains of the collagen
propeptide.

There are a

number of cases in which similar

defects, such as glycine substitutions, map very close to each
other in the same propeptide chain yet are associated with
drastically

different

phenotypes

Constantinou et al., 1990).

(Tenni

et

al.,

1988;

Glycine substitutions outside the

triple-helical domain have been identified in both mild and
severe cases (Byers, 1990).

There is an example of 3 cases

where small insertions or deletions, all located in the

c-
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propeptide caused frameshift mutations which produce three
phenotypes ranging from mild to severe {Willing et al., 1990;
Bateman et al., 1989; Pihlajaniemi et al., 1984). There are
also many cases where multiple members of a family carry the
same Type I

collagen defect and show a wide variation of

severity, even being asymptomatic {Superti-Furga et al., 1989;
Sykes et al., 1990).
It

is

possible

that

factors

such

as

local

chain

structure, domain functions and molecular interactions in the
final collagen polypeptide could modify the effect of specific
substitutions {Byers, 1990; Cohn et al., 1988). However, as
is clearly indicated in the above situations, the variable
severity of symptoms cannot be wholly attributed to a lack of
understanding of the functional domains of the Type I collagen
molecule.

Defects in other ECM components,

including other

collagen types, which interact with the various domains of
Type I collagen could clearly affect the OI phenotype.

Other Collagen Types
There are at least 15 other collagen types in addition
to Type I

collagen. They are composed of multiple distinct

polypeptide chains, and thus they are coded for by more than
25 genes {Miller and Gay, 1987). In addition to the structural
role the "classical" or "f ibrillar" collagens are known to
play in providing a scaffolding for underlying tissues, recent
discoveries have indicated that other collagen types have

15
additional properties dictated by the multiple domains in
their polypeptides. However, very little is known about how
their associations/interactions contribute to the structural
integrity of the extracellular matrix. Collagens are defined
by a triplet repeat, the presence of the modified amino acids
hydroxyproline and hydroxylysine, and by the formation of a
triple helical

structure

(Byers,

1989;

Sandell and Boyd,

1990). They can be classified into distinct groups.
The first group consist of the classical or fibrillar
collagens (Types I, II, III, V and XI). They all contain three
polypeptide chains, with a monomer size greater than 95,000
daltons

and

long,

uninterrupted

triple-helical

domains,

approximately 300 nm in length, containing the characteristic
Gly-X-Y amino acid repeat (Kuhn, 1987). They are all expressed
in

a

tissue

specific

manner

and

all

participate

in

the

formation of the characteristic fibrils known to contribute
to the structural framework and strength of connective tissue.
Their genes share a highly-conserved exon-intron organization
(Chu et al., 1984). The majority of the exons in the triple
helical coding regions are 54 bp,

or multiples of 54 base

pairs and all of them contain integral numbers of the basic
Gly-X-Y repeat, beginning with the codon for glycine (Sandell
and Boyd,

1990).

The highly

interrupted coding

sequences

contain more than 50 exons resulting in genes between 18 and
40

kilobases

(de

Wet

et

al.,

1987;

Chu

et

al.,

1985a;

Tsipouras and Ramirez, 1987; Myers et al., 1981). The coding
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sequences are divided into a nearly identical number of small
exons, and most introns regardless of size, are located in
homologous positions in each gene
Bernard et al.,

1988).

collagens

from

arise

(Ramirez et al.,

In addition,
procollagen

1985;

all of the fibrillar

precursors

and

undergo

proteolytic removal of terminal extensions as was described
for Type I collagen above (for a complete review see Kuhn,
1987).
All collagens other than the f ibrillar collagen types
described above can be referred to as non-fibrillar collagens.
These collagens do not form long fibrils and all contain
multiple interruptions in the Gly-X-Y repeat. The genes coding
for these collagens contain few 54 bp exons (Sandell and Boyd,
1990).

They can be divided into subgroups based on their

specific structural features and possible functions; however,
their placement in one group is not necessarily exclusive.
The large nonfibrillar, minor collagen types IV, VI and
VII again have monomer chain sizes that are greater than
95,000 daltons, but they all have at least one interruption
in

the

Gly-X-Y

repeat

within

the

triple

helical

domain

(Sandell and Boyd, 1990) and large terminal globular domains.
The interruptions allow the molecules flexibility which is not
possible for the fibrillar collagens (Hofmann et al., 1984).
Although this group in general is not well characterized,
analysis

of

the

genes

for

Type

IV,

a

basement membrane

collagen, has shown that the exon sizes and overall intron-
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exon patterns are very different from the 54 bp exon pattern
of the fibrillar collagens (Soininen et al., 1988; Soininen
et al., 1989). In addition, these collagens tend to aggregate
through end-to-end association of monomer (Timpl et al., 1981)
or dimer units rather than by the lateral, quarter staggered
association necessary for fibril formation.
Type

VI

collagen

is

a

highly

disulfide

bonded,

microf ibrillar component present in human blood vessels and
in the myocardium (Chung et al., 1976; Bashey et al., 1992)
as well as many other "soft" connective tissues (Karkavelas
et al.,

1988). This molecule appears to be distributed in

tissues where continuous contraction and relaxation, such as
that seen in the heart, would warrant a very flexible ECM
component that would allow the distribution of this sort of
stress (Bashey et al.,

1992). Type VII collagen, the major

protein of anchoring fibrils in epidermal basement membrane,
also exhibits properties

that

could contribute to

tissue

flexibility (Ryynanen et al., 1991).
The "short-chain" collagen Types VIII and X have monomer
chains which are half the length of the f ibrillar collagens
(Apte et al,

1992)

and have a distinct gene organization.

These collagens share common structural features in that both
contain 8 interruptions of the helix of similar sequence,
length

and

relative

locations

(Ninomiya

et

al.,

1990;

Yamaguchi et al., 1989). The small 5 kb gene for chick al(X)
collagen contains only 3 very large exons and no introns
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separating its triple helical coding sequences (Sandell and
Boyd, 1990). The 6kb human al(X) gene contains only 2 exons,
one very large and one very small (Thomas et al., 1991). In
all of these genes one large exon encodes the entire triple
helical coding region (Yamaguchi et al., 1991; Thomas et al.,
1991). The genes of the short chain collagens share almost
complete sequence identity in some regions,
half of the non-collagenous
1990).

(NCl)

such as the 3'

domain (Muragaki et al.,

In vitro studies show that Type X collagen forms a

hexagonal lattice similar to that formed by Type VIII collagen
in Descemet's membrane (Apte et al., 1992). Although the exact
function of these collagen types is unknown, Type X collagen,
expressed in hypertrophic chondrocytes, is somehow necessary
for normal bone development (Thomas et al., 1991).

"FACITs" Collagens
The final subgroup, the fibril-associated collagens with
interrupted triple helices or "FACITs" collagens
al., 1988), include Types IX,, XII, XIV and XVI

(Olsen et
(Gordon et

al., 1989; Gordon et al., 1991; Pan et al., 1992). Many of
these collagens have properties which suggest their ability
to interact with other collagens and ECM components. These
interactive

properties,

along

with

complex

regulatory

mechanisms, tissue specificity and developmentally regulated
gene expression make them particularly interesting candidates
for factors which mediate/diversify the function of the major
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fibrils in different tissues. It is therefore possible that
mutations in genes whose products have properties like these
could contribute to the OI phenotype.
All of these collagens, as well as Types VIII and X, have
monomer

chain

sizes

less

than

95, 000

daltons,

with

the

exception of Type XII (Pihlajaniemi and Tamminen, 1987), and
have many interruptions in the Gly-X-Y repeat. They are made
up of multiple collagenous domains (COL) separated by distinct
non-collagenous

(NC)

regions.

Each

of

these

regions

is

designated by a number indicating its location in the complete
polypeptide. The "FACITs" collagens do not undergo proteolytic
processing and are thus not secreted as procollagens (Shaw and
Olsen, 1991).

Although the FACITs all share these common

structural features, their sizes and primary structures vary
greatly (Pan et al., 1992). This collagen group shows a wide
variation

in

organization.

gene

structure

and

overall

intron-exon

They contain few 54 base pair exons and the

exons often do not contain integral numbers of the Gly-X-Y
repeat. All of these collagens occur in conjunction with other
fibrillar collagen types, and are somehow "associated" with
the surface of the fibril.
Type

IX

collagen

is

considered

a

proteoglycan

with

collagenous properties (Noro et al., 1983) • Found in cartilage
and corneal stroma,

it contains three collagenous and four

non-collagenous domains. Three genes code for the heterotrimer
(Ninomiya, 1985). The gene for chicken al(IX) collagen is 100
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kb, and contains short exons and multiple large interruptions
in its triple helical coding sequences.
a2 (IX)

gene,

about 10 kb in length,

smaller intrans,
(Ninomiya

In contrast,

the

contains more exons,

and therefore a much higher exon density

et al.,

1990).

The a2

chain also

contains the

covalently bound glycosaminoglycan (GAG) side chain. Despite
these differences, the size and location of the exons coding
for the multiple triple-helical regions, as well as most of
the non-collagenous regions, are structurally homologous. The
recent isolation of cDNA clones of the chick a3 (IX)

chain

indicate an overall structure similar to that of homologous
regions of al(IX) and a2(IX)

(Brewton et al., 1992).

Type IX collagen is found to be crosslinked to Type II
collagen molecules in cartilage (Vaughan et al., 1988) and is
arranged in a periodic manner along the surface of the fibril
projecting its third triple-helical, COL3, and NC4 globular
domain into the per if ibrillar matrix

(Olsen et al.,

1988;

Gordon et al., 1991). The large globular amino-terminal NC4
domain of

the

cartilage al (IX)

molecule

is

significantly

shorter and very different in structure in embryonic cornea.
Tissue-specific promoter usage and alternative splicing is
likely responsible for this variation (Gordon et al., 1989).
The

tissue-specific

variation

seen

in

the

perif ibrillar

extension of the Type IX polypeptide affords the major Type
II collagen molecule the ability to interact in a

tissue

specific manner with other collagen types and ECM components.
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Type IX collagen also contains an attachment site in the
a2 chain for a

chondroitin sulfate side chain in its NC3

domain, suggesting its role as a proteoglycan as well as a
collagen. This GAG side chain is also in contact with the
major Type II fibrils of cartilage, thus perhaps providing an
additional way to facilitate interaction between the collagen
molecules and other ECM components (Vaughan et al., 1988).
Type XII collagen was originally isolated from embryonic
chick tendons (Dublet and van der Rest, 1987; Gordon et al.,
1987) a tissue whose major fibril is Type I collagen. It has
two short triple-helical domains and three non-collagenous
domains (Gordon et al., 1990). Type IX and Type XII are about
50% identical at the protein and gene levels and have multiple
conserved cysteine residues in the NCl, COLl and NC2 domains
(Gordon et al., 1987). In contrast to Type IX, Type XII is a
homotrimer of three identical a-chains and does not contain
a glycosaminoglycan side chain. However, it does contain an
amino terminal globular domain, NC3, which is similar to, but
much larger than NC4 of al(IX)

(Dublet et al.,

intron/exon structure of portions of al(XII),

1989). The

specifically

COLl, NC2 and COL2, is homologous to that of the al(IX) and
a2(IX) chains (Gordon et al., 1989; Gordon et al., 1990). In
addition to these Type IX-like regions (which comprise only
7.7% of the molecule), recent data reveal that the complete
Type

XII

collagen

is

a

chimeric

molecule

with

multiple

functional domains including reiterated fibronectin type III
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motifs, von Willebrand factor A motifs, and Arg-Gly-Asp cell
adhesion sites (Yamagata et al., 1991).
Type XIV collagen fragments were recently isolated from
fetal bovine skin and tendon (Dublet & van der Rest, 1991) and
embryonic chick skin. This homotrimeric collagen also appears
to be another FACITs since the structure of its collagenous
domains is similar to that of Type XII, and to a lesser extent
Type IX collagen (Gordon et al., 1991; Aubert-Foucher et al.,
1992) . Electron microscopic studies suggest that Types XII and
XIV collagen could be similar in size and shape as well
(Dublet and van der Rest, 1990). In Type XIV as in Type XII,
the triple helical domains comprise less than 15% of the
intact molecule (Aubert-Foucher et al., 1992).
The recently described human Type XVI collagen gene again
resembles

the

structure

of

the

other

fibril-associated

collagen Types IX, XII and XIV (Pan et al., 1992). Many of its
10 collagenous domains contain interruptions of the Gly-X-Y
pattern and these domains are separated by 11 short noncollagenous stretches. Again, the COLl and the amino terminal
NC domain is similar to that of other FACITs collagens. In
addition, its cysteine-rich non-collagenous domains resemble
those

found

similarity,

in
and

the
the

~

elegans

expression

of

cuticle
Type

collagen.

XVI

in

This

epidermal

keratinocytes as well as dermal fibroblasts, have implied its
possible function in the epidermis. The predicted amino acid
sequence also contains three potential N-glycosylation sites

23

(Asn-X-Thr/Ser) and three Arg-Gly-Asp sites (signal for cell
adhesion). It too is thus a multi-domain molecule with both
collagenous and non-collagenous properties.
Most mammalian tissues express more than one type of
collagen although one is usually predominant. Type V collagen
is frequently associated with both Types I and III (Fessler
and Fessler, 1987) and immunohistochemical studies have shown
close association,

in vivo,

of Type V fibrils with Type I

fibrils and with basal laminae

(Martinez-Hernandez et al.,

1982; Fitch et al., 1984). It appears that Type V fibrils are
somehow involved in regulating the diameter of Type I fibrils
(Birk et

al.,

1988) .

A similar

function

has

also

been

suggested for Type XI which is associated with Type II fibrils
in cartilagenous tissue (Eyre and Wu, 1987).
The non-fibrillar, FACITs collagen Types IX and XII are
are also structurally, genetically and perhaps functionally
related (Dublet and van der Rest, 1987; Gordon et al., 1987).
It has been suggested, due to their structural similarities,
that Type XII may align similarly along the surface of Type
I and V fibrils in bone as Type IX does with Type II and XI
fibrils in cartilage (Ninomiya et al., 1990). Immunofluorescence studies have indeed found Type XII collagen only in
tissues that contain Type I collagen, but not bone (Sugrue et
al., 1989). TWo Type XII-like collagens, likely to be Type XIV
collagen,

have

been

localized

to

the

surf ace

of

banded

collagen fibrils of human and calf tendon and skin (Keene et
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al., 1991). It is possible that Type XIV in bone, and Type XII
in non-bone tissues serve similar functions in different Type
I collagen-containing tissues.
Once described as a "short-chain" collagen, low molecular
weight collagen Type XIII has features of the non-f ibrillar
Types IV and IX (Pihlajaniemi et al., 1987). Most of the exons
of the al(XIII) gene are not multiples of 54 bp and it encodes
three

collagenous

and

four

non-collagenous

domains

(Pihlajaniemi and Tamminen, 1990). The exons all begin with
a complete codon for an amino acid, a feature found in the
genes

for

the

fibrillar

collagens

(Tikka

et

al.,

1988).

Therefore, this collagen has both fibrillar and non-fibrillar
collagen features. This was the first collagen described to
undergo complex alternative splicing. As many as 5 alternative
splice sites have been identified and at least 2 species of
mRNA transcripts

are

produced

by

the

use

of

alternative

transcription initiation sites as well as alternative splicing
(Pihlajaniemi and Tamminen, 1990) . This gene also contains one
exon which encodes a unique Gly-X-Y repeat extending into a
domain that is not triple helical.

(Tikka et al.,

Therefore,

a

Type

XIII

collagen

has

structure

1988) .

which

is

different from all other collagen types.
As more unique features of the non-f ibrillar collagen
genes are discovered, the diverse domains of these collagenlike ECM components imply functions beyond the traditional
structural role attributed to fibrillar collagens. There are
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likely to be important interactions of these molecules with
the fibrillar

collagens and with other ECM components

in

determining the connective tissue type, its basic properties,
structural integrity, and capacity to withstand stress.
Additional collagen-like genes continue to be discovered.
Recent studies have shown that a pro-a2(I) cDNA probe detects
two previously-undescribed loci in a collagen-like gene(s)
other than the already-characterized f ibrillar collagen genes
(Doering et al., 1990). Deletions of heterogenous size have
been detected at one or the other of these sites in genomic
DNA of Type III OI patients. The deletions are significantly
more prevalent in these patients than in the normal population
and frequently occur spontaneously in patients who have no
clear family history of the disease (Doering et al., 1990).
such correlations suggest that these collagen-like deletion
sites could be contributing to the OI phenotype.
One site,
fragment

in

chromosome 17

detected as a

normal

4. 6 kb Hind III restriction

individuals,

(Cammarata et.

al.,

has

been

1991).

localized

to

The cloning and

sequencing of this fragment will allow identification of the
gene product of this locus, characterization of the deletion
site in OI patients, and thus ultimately an understanding of
how mutations at this
phenotype.

locus might play a

role in the OI

MATERIALS AND METHODS

overall Approach
In order to characterize the new collagen locus, a Charon
21A phage library containing Hind III restriction fragments
of human chromosome 17 was screened for a 4.6 kb collagen
sequence-containing fragment.

Positive phage isolates were

plaque purified and the insert-containing phage DNA isolated.
The 4.6 kb insert was recloned into a plasmid vector so that
a

preliminary restriction map could be

constructed.

This

allowed the subcloning of smaller fragments, containing triple
helical

coding

sequences,

to

be

sequenced.

Sequence

comparisons using Genetics Computer Group software (Devereux
et al., 1984) were performed to compare these sequences to
other known collagen genes and collagen-like sequences in
order to

identify the

collagen group that

the

new

locus

represents.

Library Screening
The previously described pro-a2 (I) cDNA clone Hf32 (Myers
et al., 1981) was used to screen a human chromosome 17 library
(LL17NS02/ ATCC#57759)

obtained from American Type Culture

Collection, Rockville, MD. This phage library was constructed
26
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in the Charon 21A vector with Hind III digested restriction
fragments of human chromosome 17. The
JM109

was

infected with

the

~

coli bacterial strain

recombinant

phage

particles

(Benton and Davis, 1977) and incubated at 37°C overnight on
NZCYM agar plates (Sambrook et al.,

1989). Plaque lifts to

nylon membranes (NEN, Bethesda, MD) and lysis of the membranebound

phage

instructions.

were

done

according

to

the

manufacturer's

10 6 phage clones were screened.

A total of

Plaque purification was carried out using previously described
methods (Sambrook et al., 1989).

Nick Translation and Hybridizations
The cDNA clone Hf32, digested with EcoRI and PstI, was
32

P-labelled by nick translation (Rigby et al., 1977) to an

average specific activity of 4.5 x 10

8

cpm/µ.g.

Prehybrid-

ization was carried out for a minimum of 5 hours at 37°C
(Doering

et

al.,

1982;

Rosenthal

and

Doering

1983)

in

hybridization solution (50% formamide, 0.9 M NaCl, 50mM Tris
pH7.5, 1%

sos,

lOug/ml

denatured~

coli DNA). Denatured nick

translated probe was added to the prehybridized membranes and
incubation continued at

37°C

for

a

minimum

of

16

hours.

Membranes were washed twice for 10 minutes at room temperature
in 2X SSC (lX SSC is 150 mM NaCl, 15mM sodium citrate, 0.1 mM
EDTA), twice for 30 minutes at 50°C in 2X SSC,
twice

for

30

minutes

at

room

temperature

in

1%

sos

0.5X

and
SSC.
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Autoradiography was done using Kodak XAR X-ray film and Dupont
Lightning-Plus intensifying screens when necessary.
Rehybridization of any additional probes to previously
hybridized membranes first required removal of the original
probe by very high stringency washes. The membrane was first
washed with a

O. 4M NaOH solution,

Tris-HCl, 0.1%

sos,

minutes.

If

the

then with O. lXSSC,

O. 2M

in a shaking water bath at 42° C for 30

probe was

not

sufficiently

removed

this

procedure was repeated and/or a second method was carried out.
The additional method required boiling the membrane

in a

solution of O. lxSSC, 1% SOS for 3 O minutes. This procedure was
also repeated as necessary to completely remove the probe.

DNA Isolation
The purified recombinant phage DNA was isolated by the
standard plate lysate method (Maniatis et al., 1982) with the
following

Harvested

modifications:

phage

particles

were

treated with RNase A and DNase I at a final concentration of
10 µg/ml and 5 µg/ml respectively. The PEG precipitated phage
particles were incubated overnight on ice. After addition of
SDS/EDTA,

lysis

was

carried

out

for

1

hour

at

68°C.

Isopropanol precipitation was carried out overnight at -20°c.
Plasmid purification was carried out using Qiagen Tip-100
anion

exchange

columns

(Chatsworth,

manufacturer's instructions.

CA)

according to the
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Restriction

Mapping;

Alu

Repetitive

Sequence

and

Exon

Localization
Restriction

mapping

methods using single,

was

carried

out

by

established

double and triple digests

1977; Peterson et al.,

1980; Rosenthal et al.,

(Doering,
1984). All

restriction enzymes were purchased from Bethesda Research
Laboratories (Bethesda, MD) or Promega Biotech (Madison, WI)
and used in the suppliers' recommended buffers. Restriction
digests were stopped by addition of SOS and EDTA to final
concentrations

of

0.5%

and

lOmM

respectively.

Gel

electrophoresis was carried out using 1% or 1.2% agarose gels
(Rosenthal and Doering, 1983) and the DNA was transferred to
NEN (Boston, MA) Gene Screen Plus membranes using the alkaline
transfer method (Reed and Mann, 1985). DNA size markers were
lambda phage DNA digested with HindIII and phi-X 174 phage DNA
digested with HaeIII.

Triple helical

coding regions were

identified using the Hf32 probe and hybridization conditions
described above. Localization of Alu repetitive sequences was
done using the Alu probe Blur 8

(Deininger et al.,

1981) .

Hybridization conditions were the same as those described for
the Hf32 probe above except that the hybridization solution
contained 1.0M NaCl instead of 0.9M as for Hf32.

Subcloning and DNA Sequencing
The 4. 6 kb phage DNA insert and the 1. 6 kb EcoRI/PstI and
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1. 5 kb EcoRI / SmaI restriction fragments

containing triple

helical coding sequences were subcloned by standard methods
(Sambrook et al., 1989) into the pUC13 (Vieira and Messing,
1982) and pGEM7Zf+
These

subclones,

(Promega Biotech, Madison, WI)
p4.6EP

and

p4.6ME

vectors.

respectively,

were

sequenced by the dideoxy method (Sanger et al., 1977).

The

double-stranded

template

and

and

reannealed

follows

prior

reactions.

as

primer
to

were

denatured

extension/termination

Three micrograms of template DNA and

o. 5 pmol

primer DNA were combined in a total volume of 20.0 µl. NaOH
and EDTA were added to a final concentration of

o. 2M and o. 2mM

respectively and the mixture was incubated for 5-6 minutes at
85°C. The tube was immediately placed on ice, and 6.0 µl of 3M
NaOAC, pH 5.2 and 60.0 µl 100% EtOH were added to precipitate
the denatured DNA. This solution was placed at -20°C for 20
minutes. The DNA was pelleted by centrifugation at 10,000 rpm
in an SHMT rotor (Sorvall/E.I. duPont, Newtown, CT)
minutes and washed carefully with 70% EtOH.
pellet

was

resuspended

in

distilled

H2 0

for 20

The dried DNA
and

reannealed

(incubated) for 15 minutes at 37°C (p4.6EP) or 5 minutes at
37°C followed by 5 minutes at room temperature (p4.6ME).
The extension and termination reactions were carried out
according to the manufacturer's instructions for sequencing
double stranded DNA using the "Sequenase" kit (United States
Biochemical

Corp.,

Cleveland,

OH)

and/or

the

"AmpliTaq"

sequencing kit (Perkin-Elmer Cetus, Norwalk, CT) . The DNA was
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tagged by including

35

S-labelled dATP nucleotides during the

extension reaction. When obtaining sequence information from
inserts in the pUC13 vectors the -40 primer adjacent to the
EcoRI site was used (see Figure 7c). Sequence extension began
from the EcoRI end of the insert and continued to the left
toward the helical coding region. When obtaining information
from the pGEM7Zf+ clones, the T7 primer was used (Figure 7d) .
Again, sequence extension was from the Eco RI site, or in the
case of the nested deletion clones

(Figure 7e),

sequences

adjacent to this site and proceeding to the left through the
helical coding region.
(Perkin-Elmer
extension

reactions,

instructions,
confirming

Cetus,

The nucleotide analogue deaza-dGTP

Norwalk,

CT)

according

was
to

also
the

used

in

manufacturer's

in conjunction with 40% formamide gels,

sequence

in

regions

with

the

complex

for

secondary

structure.

Generation of Nested Deletions
The subclone p4.6ME was used as a template to generate
nested deletions by exonuclease III digestion from the Eco RI
site. This procedure was carried out by using the "Erase-abase" system (Promega Corporation, Madison, WI) according to
the manufacturer's instructions.

Three overlapping clones,

p4.6ME-5, p4.6ME-7 and p4.6ME-9 with deletions of appropriate
sizes (Figure 7e) were chosen for further sequencing.
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Sequencing Gels
Sequencing gels containing either 8% or 6% acrylamide/bis
(37.5:1)

and

7M

sequencing data.

urea

were

used

to

obtain

most

of

the

In order to sequence regions of secondary

structure formamide was added to a final concentration of 40%
when necessary. After electrophoresis, the sequencing gel was
soaked for 15 minutes in 10% acetic acid/ 10% methanol solution
or 10% acetic acid/20% methanol for formamide gels.

It was

then transferred to Whatman 3MM filter paper by established
methods (Kozak et al., 1991), dried in a gel dryer (Bio-Rad
Laboratories,

Hercules,

CA)

for a minimum of 2 hours and

autoradiographed. The entire sequence was read a minimum of
3 times from independent gel runs in order to confirm its
accuracy. Sequence analysis was done with the aid of the VAX
network system (Loyola University Chicago) and the Genetics
Computer

Group

sequence

(Devereux et al., 1984).

analysis

program,

version

7.1

RESULTS

Isolation and Confirmation of Cloned Sequences
In order to characterize the new collagen-like Site 2
locus, a Charon 21A lambda phage library containing HindIII
restriction fragments from human chromosome 17 was screened
for the 4. 6 kb collagen sequence-containing fragment. At least
10

6

32

plaques were screened with the

P-labelled a2 (I)

cDNA,

Hf32, and 107 positives were identified. The high number of
positives was not suprising since a full chromosome's worth
of

fragments

is

contained

in

1. 4

x

10 4

clones.

Twelve

positives were picked for plaque purification. Purification
required
density

plating

the

phage

particles

at

the

appropriate

(approximately 100-200 plaques per plate)

so that

individual positive plaques were well separated and could be
easily

identified

and

isolated.

This

assures

that

each

positive isolate contains a homogeneous population of phage
particles

representing

a

single

clone.

Five

independent

isolates were identified and DNA was prepared from them. When
digested with HindIII,

three of the clones were found to

contain a 4.6 kb insert, that hybridized strongly with the
a2(I) cDNA probe (Figure la). The other two clones contained
a

4.4

kb

and

a

6.0

kb

insert
33

respectively,

that

also

34
hybridized with the Hf32 probe (Figure la).
The blot of the HindIII digested phage

isolates was

stripped and rehybridized with the al(I) cDNA probe, Hf677,
under higher stringency conditions, (1XSSC/65°C). There was no
hybridization of the 4. 6 kb cloned inserts but there was
hybridization to both the 4.4 and 6.0 kb inserts (Figure lb).
These results confirm that the 4.6 kb fragment is not a member
of the already characterized COLlAl gene which is also located
on chromosome 17. Use of high stringency conditions ensures
this because a genuine COLlAl sequence would cross-hybridize
even

under

these

high

stringency

conditions.

Positive

hybridization of the al(I) probe, even at high stringency, to
the cloned 6.0 kb fragment confirm that this is the same 6.0
kb fragment known to be a member of the COLlAl gene (Barsh et
al., 1984). Although the 4.4 kb insert is also detected by
Hf677, there is no fragment of that size in the COLlAl gene.
Therefore,

the

nature

of

this

clone

is

undetermined.

No

further study has been done on this isolate.
The above hybridization results confirm that the 4.6 kb
cloned fragment represents a distinct locus and is not part
of the COLlAl gene. The sequences within the 4.6 kb fragment
thus represent a new human collagen-like locus on chromosome
17 which has not previously been described.
DNA from an isolate containing a 4. 6 kb insert was chosen
for further study. It was first used to confirm that this was
indeed a clone of the 4.6 kb HindIII fragment characteristic
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of Site 2. Hybridization of this phage isolate to HindIII or
PstI digested genomic DNA of a normal and an OI III affected
individual revealed a smear of hybridization in all lanes
under

low

stringency

conditions

{Figure

2a) .

This

hybridization smear indicated that the cloned DNA contained
repetitive sequences dispersed throughout the genome, as well
as the originally identified collagen-like sequences.
When the blot was rewashed at higher stringency {O. lXSSC,
65°C) the smears were greatly diminished and distinct bands
could be visualized.

In the normal

individual the 4. 6 kb

HindIII and 5.2 kb PstI fragments characteristic of Site 2 are
detected by the probe (Figure 2b, lanes 2 & 4). The detection
of a doublet in these lanes suggests that this individual is
heterozygous for a 300 bp deletion at this locus. These were
the only fragments detected in the genomic DNA of the normal
individual. In the DNA of the OI affected individual the probe
detects only a 4.4 kb fragment in the HindIII digest or a 5.0
kb fragment in the PstI digest. This individual is known to
be

homozygous

hybridization

for
of

a
the

200

bp deletion

phage

isolate

at
probe

this
to

locus.
only

The

these

fragments representing the collagen-like locus confirmed that
the 4. 6 kb fragment characteristic of this locus had been
successfully cloned.
To determine the identity of the repetitive sequences
contained within this

clone the

southern

blot containing

HindIII digested phage isolate DNA was hybridized to the Alu
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sequence probe Blur 8 (Figure le). The positive hybridization
indicates that at least some of the repetitive sequences in
the 4.6 kb clone are members of the Alu dispersed family.

Restriction Mapping of the HindIII Fragment Cp4.6)
In order to facilitate the mapping and characterization
of the phage isolate, the 4.6 kb insert was excised from the
HindIII site of Charon 21A and recloned at the HindIII site
of the pUC13 plasmid vector, forming p4. 6. Restriction mapping
was

carried

out

by

established

methods

(Doering,

1977;

Peterson et al. , 1980; Rosenthal et al. , 1984) . A complete map
of the 4.6 kb cloned fragment is shown in Figure 3. Southern
blots of restriction digests, hybridized with the Hf32 cDNA
probe,

allowed

localization of

the triple helical

coding

region to an 800 bp region extending from EcoRI to PvuII
within a 1. 6 kb EcoRI to PstI restriction fragment {Figure 4) .
Clearly the 1.6 kb EcoRI/PstI fragment hybridized with the
probe (Figure 4a, lane 4) indicating that this region contains
helical coding sequences.

In p4.6 neither the HindIII/PstI

fragment to the left of the helical coding region (see Figure
3),

nor the HindIII/EcoRI fragment to the right

(data not

shown) of the 1.6 kb EcoRI/PstI fragment, hybridized with the
Hf32 probe. Upon double digestion of p4.6 by the enzymes Aval!
and HindIII a doublet is produced at the 1.4-1.5 kb position.
The upper fragment of the doublet is a HindIII/AvaII insert
fragment shown to the left of the triple helical coding region
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in

Figure

3.

When the

Southern blot

of

this

digest was

hybridized with Hf32, only the lower, vector fragment of the
doublet was detected (Figure 4b,
PstI/PvuII

lane 5).

There is also a

subfragment contained within the HindIII/AvaII

fragment which does not hybridize (Figure 4b, lane 7). Thus,
lack of hybridization to the HindIII/AvaII and PstI/PvuII
fragments allowed localization of the helical-coding region
solely to the EcoRI/PvuII portion of the EcoRI/PstI fragment.
The al (I)

probe Hf677

was

also rehybridized to the

same

Southern blot in order to determine if any other regions
contained

triple

helical

coding

sequences.

No

additional

regions were identified with this probe (data not shown).
The presence of collagen-like sequences in the 1.6 kb
EcoRI/PstI

restriction

fragment

was

reconfirmed

by

its

susceptibility to digestion with Sau96I. This approach has
previously

been used

in

characterizing

other

collagenous

protein coding regions (Vasios et al., 1987). The recognition
sequence of this restriction enzyme is GGNCC. This is the same
sequence that codes for the amino acids Glycine
Proline

(CCA or CCT). Thus,

(GGN)

and

because glycine is present as

every third residue and proline is often in the X position of
the

collagen

triplet,

triple

helical

coding

regions

are

extremely suseptible to digestion with this enzyme. The clone,
p4.6, was triple digested with Sau96I, EcoRI and PstI so that
the effect of Sau 961 on the 1.6 kb EcoRI/PstI fragment could
be examined. No sequences of the EcoRI/PstI fragment greater
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than 200 bp remained intact (Figure 5, Lane 3),

indicating

that multiple Sau96I sites were present in this restriction
fragment. When p4.6 is digested with EcoRI and PstI only, 4800
bp (see Figure 4a, lane 4) and 750 bp fragments are generated
in addition to the 1600 bp fragment.

After digestion with

Sau96I the 4800 bp fragment remains only as a 2000 bp fragment
containing both insert and vector sequences to the right of
the EcoRI/PstI

fragment

(see Figure 3).

The pUC13

vector

contains multiple Sau96I sites which, upon digestion produce
fragments much smaller than 2 kb. Therefore, this fragment
must span the vector-insert junction. The distance from EcoRI
to HindIII on the right however, is larger than 2000 bp. Thus,
there must be additional Sau96I sites close to the EcoRI site
in the right-hand EcoRI/HindIII fragment of the clone.
Hybridization

of

a

Southern

blot

containing

various

restriction digests of p4.6 to the Alu sequence probe Blur 8
allowed the identification of a minimum of three restriction
fragments

containing Alu repetitive sequences

(Figure 6).

These sequences are present in the 1.6 kb EcoRI/PstI helicalcoding fragment,

and on both sides of this fragment.

flanking fragments were:

The

the 800 bp SstI/HindIII fragment and

a more weakly hybridizing 800 bp HindIII/Pst I fragment. The
850 bp PstI/PvuII portion of the 1.6 kb helical-coding region
contained all the Alu sequences within this fragment (data not
shown). These repetitive sequence regions are indicated by an
asterisk in Figure 3.
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Subcloninq and Sequencing
The helical-coding region of p4.6 remains the focus of
the subsequent data in this thesis because its collagen-like
nature

is

deletions

of

greatest

in

this

unpublished)

interest.

region

and

The
Type

correlation
III

OI

make it of particular interest.

between

(Michaels,
In order to

facilitate the fine structure mapping and sequencing of the
helical-coding region, the EcoRI/PstI fragment was subcloned
into

the

pUC13

plasmid

vector.

A

schematic

diagram

illustrating the construction of this subclone (p4.6EP), and
subsequent constructs used in sequencing the helical region,
is

presented

in

Figure

7.

This

arrangement

simplified

restriction digest patterns and placed the EcoRI/PstI fragment
directly adjacent to vector sequences for which sequencing
primers were available (Figure 7c) .
tions

of

Hf32

to

restriction

Southern blot hybridiza-

digests

of

this

subclone

confirmed the presence of at least two regions containing one
or more AvaII sites (recognition sequence: GGACC). The first
site, estimated at a position 150-200 nucleotides to the left
of EcoRI, marks the point at which the triple helical coding
region begins.

At a position 680 bp from EcoRI,

the most

distal PvuII site defines the approximate endpoint of the
triple helical coding region (see Figure 3).
The next goal of this project was to sequence this triple
helical coding region. Although it was clear that the region
did not begin until the first AvaII site, the presence of

40
multiple AvaII sites very close to each other, and the lack
of other convenient restriction sites, made subcloning only
the

immediate coding region impossible.

Therefore dideoxy

sequencing using the "Sequenase" kit (U.S. Biochemical Corp.)
was carried out beginning at the

11

-40 universal primer" site

adjacent to the EcoRI cloning site (Figure 7c).
At position 230 (230 nucleotides to the left of EcoRI of
Figure 3), the first AvaII site was reached. This marked the
beginning of the triple helical coding region. Approximately
300 nucleotides of sequence was determined using the Sequenase
kit (Figure 8) . At that point the ability to resolve sequence
using the -40 primer was lost. In addition, the limitations
of

the

Sequenase

method

prevented

the

determination

of

sequence in areas of complex secondary structure near the
AvaII sites

(see Figure 9a). This sequence not only has a

repetitive nature but is also very GC rich. DNA polymerase I,
the enzyme employed in the Sequenase kit, is sensitive to the
higher temperatures required to sequence a GC rich double
stranded region. As a result, reliable sequence extension in
these GC rich regions was difficult to obtain in regions
greater than 200 nucleotides from the primer. Figure 9a shows
a typical sequence "ladder" which results from situations such
as this.

Use

of

internal

primers

based

on

new

sequence

information usually allows further sequence determination, and
sequence extension closer to these internal primers reduces
premature termination due to secondary structure. However, in
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this case the identification and use of internal sequencing
primers was not possible due to the repetitive nature of the
sequence beginning at position 128 (Figure 10).
Due to the difficulties using the "Sequenase" method, all
sequence obtained from position 160 to 300 (position numbering
starts at EcoRI and moves to the left in Figure 3)

was

reconfirmed using the "Ampli-Taq" sequencing kit {Perkin-Elmer
Cetus) • This kit employs Taq polymerase, a very stable enzyme
at the higher temperatures (45-72°C) needed to reduce secondary structure in GC rich areas. Although ambiguous sequence
was confirmed and some additional sequence was obtained,
resolution was lost using this method at position 400.
The majority of the EcoRI/PstI fragment was then isolated
and subcloned as a 1.5 kb EcoRI/SmaI fragment (see Figures 3
and 7)

into the pGEM7Zf+ vector

(p4. 6ME),

so that nested

deletion subclones could be generated for further sequencing.

Creation of Nested Deletion Subclones
The

"Erase-A-Base"

system

{Promega

Biotec)

employs

exonuclease III for the serial removal of nucleotides from the
EcoRI digested end of p4.6ME. The extent of digestion is time
dependent and allows the generation of a series of clones in
which the 3' sequences are brought closer to the primer. This
method allowed the generation of a series of clones containing

overlapping sequences covering the remainder of the triple
helical coding region (see Figure 7e).
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Results Obtained with Sequencing Data Generated

The nucleotide sequence and complete map. The deletion clones
p4. 6ME-5,

p4. 6ME-7 and p4. 6ME-9

generate the remaining

435

{Figure 7e)

nucleotides

of

were used the
sequence which

extended 50 nucleotides beyond the most distal PvuII site (see
Figure 3). This covered most,

if not all,

of the helical-

coding region homologous to Hf32. The entire 735 nucleotides
of

sequence

generated

by

the

above

methods

will

be

subsequently ref erred to as "NT7 3 5". The complete sequence
{Figure 8) of NT735 confirms the presence of all restriction
sites identified previously (Figure 3). Figure 9b includes a
representative example of the acrylamide gels from which the
sequence information was obtained.

In contrast,

Figure 9a

shows the sequence "ladder" caused by premature termination
of sequence extension due to secondary structure in GC rich
regions.
In addition to the site already identified by restriction
mapping, two additional PvuII sites are present. That site
most distal from EcoRI (farthest left), already determined by
restriction digests,

is at position 684, approximately 275

nucleotides from the first site (closest to EcoRI). Another
site

is

located

equidistant

between

these

two

sites

at

position 408 (see Figure 3 and 8). The presence of this third
site at position 408 explains why no 275 bp PvuII restriction
fragment could be visualized in restriction digests.

Upon
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digestion,

small fragments

(approximately 137 bp each)

are

generated that are not resolved on a 1 or 1.2% agarose gel and
also did not hybridize when restriction mapping and coding
region localization were done. Also identified were the exact
location of multiple AvaII restriction sites which had been
previously difficult to determine due to their proximity to
each other (see Figure 3 or 8). Sequencing data also revealed
that single Sau96I (GGNCC) sites are always next to each of
the PvuII sites

(CAGCTG)

in addition to the Ava II sites

(GGA/TCC). As predicted, there are many (7) Sau96I sites in
the helical-coding region of the EcoRI/PstI fragment.

Basic organization. Analysis of the percentage of each of the
four nucleotides within this sequence shows that the double
stranded sequence contains 60% GC pairs. This GC richness is
consistent with other collagen sequences
1983).

From

position

128

to

721

there

(Bernard et al.,
are

at

least
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uninterrupted direct repeats composed of the consensus 18
nucleotide basic repeating unit, AAG ACC AGC AGC CCA GAC, each
having a minimum of 83.4% identity to this sequence (Figure
10). There are three brief interruptions. Each interruption
is 9 nucleotides long and begins with a PvuII restriction site
(indicated by carats and underlined

in Figure 10).

These

interruptions are insertions which disrupt the direct repeats
at these locations. However, their presence results in the
coding of two perfect triple helical 9-mers with an amino acid
sequence of

(Gly-X-Y) 2 in the reverse translation at these
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locations. There are also multiple thymidine insertions ("T"insertions)

which interrupt the direct repeat at various

locations in the NT735 sequence (see Figure 10).
Although the basic repeating unit itself is not a strict
triplet repeat sequence, a single nucleotide substitution, "C"
for "A" in the fourth position, makes it so. Interestingly
though, very few repeats contain this substitution. When it
does occur, a "T"-insertion also occurs in that repeat making
it 19 nucleotides long. For those repeats in which the "T"
insertions occur subsequent to a PvuII site,

two perfect

triplet repeats adjacent to each other also occur. Again,
these occur in the reverse translation. For example, position
480 to 463 contains two Gly-X-Y 9-mers (refer to Figure 8 or
10) • In addition, separated by a single nucleotide at position
462, this occurs again from position 461 to 444. This occurs
again at the second PvuII site and in the subsequent repeats
with "T"-insertions. All of these perfect triplets occur in
the reverse frames. However, because of the single nucleotide
separating them, each pair of triplets occurs in a different
reading frame.

Higher order repeats. Higher order repeats in NT735 were
identified with the aid of the GCG programs "Repeats" and
"Find Patterns". In addition to the 18 nucleotide (nt) direct
repeats this sequence also contains two 110 nt direct repeats
with 93% identity from positions 148-256 and 257-366 with a
single nucleotide insertion (Figure lla). It also contains
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three 137 nt direct repeats at positions 291-429, 430-566, and
567-703; each of which contains a PvuII site at homologous
positions in the repeat

{Figure llb).

These repeats have

between 92 and 99.27% similarity. No repeats longer than this
were found. Noteworthy however, are four 54 nt repeats which
were rejected because their identity {85%) was not significantly different from that of the 18 bp basic unit {83.4%).
A repeat organization with higher similarity than the basic
unit, such as that seen in the 110 and 137 nucleotide repeats,
indicates that these sequences are more recently evolved than
those of the early basic unit {Carnahan et al., 1993).
The 18 nucleotide tandem, direct repeat and its higher
order

repeats

considering

are

that

not
most

necessarily
collagen

nucleotide

triplet-coding

insertions

and

PvuII

basic

insertions

a

suprising

sequences
unit.
are

finding

contain

However,

present

at

a

9

the

"T"-

the

same

positions in each of the 137 nucleotide repeats, indicating
that the insertions occurred prior to the larger repeat {137
nt)

duplication event

involved in the evolution of these

sequences.

Protein translation. Using the GCG program routine "frames"
{Figure

12),

the

analysis

of

the

sequence

translation

indicates the presence of large open reading frames {greater
than 200 nt's long) in the three reverse translation frames
{D, E and F). In the forward translation several short open
reading frames are confined to the first 300 nucleotides {100
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amino acids) of the sequence (Figure 12). Open reading frames
stop when an end codon is reached and only begin again if a
methionine residue is encoded.

Because the reverse frames

contain the longer, and more collagen-like reading frames, the
remainder of the sequence analysis results will focus on these
frames unless otherwise stated.

Amino acid composition. Although the 245 amino acid long
protein translation (frame F is longest) does not represent
a strict triple-helical coding sequence containing the {Gly-XY) n repeat for more than two triplets and does not contain
many lysine or proline residues, it does contain glycine at
consistent and regular intervals of either every third, sixth
or ninth codon in the reverse frames.

All of the reverse

frames contain patterns similar to this (Figure 13). The GCG
program routine "Codon Frequency" was used to examine the
protein translation

in these

frames.

In

addition

to

the

abundance of glycine residues {16% maximum) all three frames
contain nearly 22% of the non-polar residue
reverse

translation

frames

also

include

leucine.

high

The

amounts

of

alanine (max. 13%), valine (9%) and tryptophan (9%). All are
nonpolar

residues

which

contribute

to

a

high

hydrophobicity of a molecule.

In addition to a

content,

bonding residue

present

the polar disulfide
in

an

abundance

equivalent

to

that

degree

of

10% serine
cysteine

of

the

is

non-

f ibrillar collagens (7.7%). Suprisingly, neither proline nor
lysine are present in noteably high amounts, since these are
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abundant in collagen sequences.
The GCG program routine "Codon preference" is a framespecif ic gene finder that recognizes protein coding sequences
by examining the specific codon frequency and GC bias or
wobble in the translation of a

sequence.

Codon preference

analysis suggests that the NT735 sequence contains expressed
protein coding regions (Figure 14). In all frames the average
codon preference is much higher (upper third of graph) than
that of a random sequence. Although GC bias does not rank as
high as codon preference,

it is still clearly higher than

would be seen for an untranslated or random sequence (bottom
third of graph). These data indicate that the coding sequence
of the reverse frames is likely to contain pref erred codons
which occur in genes that are expressed.

Nucleotide

sequence

comparisons.

comparisons to other human collagen sequences
GenEMBL

database

indicated

that

sequence

Nucleotide

NT735

has

in the GCG
the

highest

similarity to the 3' end of the cDNA sequence for human proa2 (I) collagen (Locus=HUMCOLL) . The region of optimum identity
or "bestfit"

is that which includes triple-helical coding

sequences of the probe, Hf32 (Figure 15). These results were
expected since this was the probe used to isolate the clone.
This collagen locus has nearly 52% identity to NT735 in a 690
bp overlap (data not shown). The region of "bestfit" (position
240 to 395 of NT735) within this region has 67.32% identity
in a 175 bp overlap with four gaps.
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Also having high sequence similarity to NT735 is the 3'
end of pro-al(!) collagen, represented by the sequences of two
cDNA clones,

Hf404

&

Hf677

(Locus=Humcglpal).

With

52. 5%

identity in 621 bp overlap, the "bestfit" region within this
was 64.15% in a 122 bp overlap with 3 gaps (Figure 16). This
region was contained within sequences of the cDNA clone Hf677.
As expected, this probe, previously used as a negative control
to confirm that our sequence was not a part of the al (I)
collagen locus, has somewhat less sequence identity to NT735
than the a2(I) locus. Although less similar than sequences of
Hf32, it is not unexpected that this locus would also have
high sequence similarity to NT735, since the two chains of
Type I collagen are very similar to each other.
The above sequence comparisons are consistent with the
hybridization
conditions

results

used,

the

obtained.
minimum

Under

the

similarity

most

stringent

necessary

for

hybridization of Hf32 to occur is in the range of 65-75%.
Since there is 67.32% identity between Hf32 and NT735 it is
now clear why positive hybridization results were sometimes
weak or inconsistent (data not shown). The conditions used
approach the minimum similarity necessary for hybridization
of the Hf32 probe to NT735. These ranges of similarity were
determined by mathematical

calculations

of

Tm values

for

reassociation in formamide (Mcconaghy et al., 1969). The upper
value for the range is determined by including in the Tm
calculation only the GC pairs in the two sequences. The lower
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value was calculated by including the total GC content within
NT735 in the region of similarity. It is however, difficult
to assess the effect of gaps on hybrid stability and equally
difficult to quantitate this effect.
The minimum similarity necessary for hybridization of
Hf677 to NT735 is in the range of 66.72-79.21%. This value is
higher than the actual identity for these sequences (64.15%).
According to these figures Hf677 should not hybridize to NT735
under the conditions used,

and in fact

it did not.

This

confirms the accuracy of the negative hybridization results
with this probe (see Figure lb).
In the above collagen sequences examined the reverse
strand of NT735 has the highest sequence similarities. This
is consistent with the analysis of open reading frames (Figure
12) indicating that the reverse frames contained long ORF's
and codon preference data (Figure 14) suggesting these frames
are likely to contain genuine protein coding sequences.
Other Type

I

collagen

sequences

have

lower

sequence

identity to NT735 than Hf32 sequences. For example, the 5' end
of both al and a2 chains of Type I collagen showed nucleotide
sequence

identity

over

similar

lengths;

however,

bestfit

results indicated lower optimum identity, and in the case of
a2(I), over much shorter lengths (data not shown).
Other collagen types also have high sequence identity
with overlaps of up to 550 bp (Table 1). These include the
cDNA sequence of the chicken a2(I)

collagen gene,

and the
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alternatively spliced transcripts of the Xenopus laevis al (II)
collagen gene which contains many exons significantly larger
than the 54 bp primordial unit. The genomic sequences of the
intronless cuticle collagen gene of

c.

elegans have similarity

to the forward strand as does the D. melanogaster collagen
gene. The latter is also suggested to belong to the family of
basement membrane or cuticle collagens,

and contains large

exons. Large coding regions such as these are characteristic
of the non-fibrillar collagens.

Since NT735 also contains

large ORF's, this suggests it too has an organization similar
to non-fibrillar collagens.
In addition, the human Type XVI FACITs has nearly 75%
identity in a 97 bp overlap and chicken Type XIV FACITs has
54% identity over almost a 400 bp overlap {Table 1). Various
short

stretches

of

the

Type

XIV transcript

similarity when the bestf it is examined.
FACITs)

approach

Types IX

60%

(also a

and X collagen of various species also have 50-60%

identity over short stretches. Much of the similarity to these
non-f ibrillar collagen genes
NT735.

This

is

unexpected

is

in the

given that

forward
the

Type

strand of
I

and

II

collagen similarities are in the reverse strands. The reverse
frames of NT735 are those with the large, uninterrupted ORF's,
a feature characteristic of the FACITs.
Nucleotide sequence comparisons to the entire database
showed the highest sequence identity in the forward strand is
to the Wheat Glu-10-lb gene for HMW wheat glutenin subunit 5
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(see Table 2). The sequence has as much as 67% identity over
639 bp with 12 gaps. This is the highest identity with the
longest region of similarity identified by the GCG program.
This identity matches that of human a2(I)

collagen but has

many more gaps and a longer overlap. If the equivalent number
of gaps as a2(I)

collagen (4) are allowed, the identity to

NT735 is still 50% over 557 bp. Many genes coding the subunits
of

this

wheat

seed

storage

protein

have

a

nucleotide

similarity of 55-65%, often over large (400-500)

overlaps.

Much of this similarity is in the central repetitive coding
domain of the glutinen genes.
subunit

5,

are

of

particular

The HMW subunits,
importance

in the

such as
glutinen

molecule because the cysteine residues at their termini confer
an unusual secondary structure contributing to its elastic
properties.

(Tatham et al., 1984). The above properties and

its highly repetitive nature suggest that the wheat glutinen
protein is the equivalent of human elastin, an ECM component
which shares some characteristics of the fibrillar and nonfibrillar collagens (Indik et al., 1990).
Because

the

above

information

was

relevant,

an

independent sequence comparison of NT735 to elastin coding
sequences

using

the

"Fasta"

subroutine

was

done.

This

comparison indicated a 55% identity over 345 bp. A subsequent
"bestfit" analysis indicated 63% similarity over 134 bp (1
gap) to an exon which codes for a glycine rich, hydrophobic
domain of the human elastin protein (Table 2).
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Fasta comparisons of NT735 to the entire database also
indicated high identity in the forward strand for the
virilis

mastermind

gene which

codes

for

a

large,

~

highly

repetitive nuclear protein required for normal CNS development. The D. melanogaster mastermind gene had slightly lower
identity. In both species the similarity lies in the region
which

contains

the

well

characterized

motifs

called

OPA

repeats. OPA repeats are defined by a (CAX)n repeat, where X
is an A or G, and n<31. These repeats are common to a variety
of developmental

regulator genes.

Other genes which have

noteworthy sequence similarity to NT735 are summarized in
Table 2. Many of these genes code for very large proteins,
contain long ORF's, and/or contain OPA or other homopolymeric
repeats. The relative significance of these sequence similarities will become more clear when the coding strand and reading
frame of this new collagen-like sequence is determined.

Amino acid sequence comparisons. The first approach to amino
acid sequence comparisons employed the GCG routine "Tfasta"
to examine the amino acid translations of the genes contained
in the GenEMBL database. Consistent with the above results,
HUMCOLL, the a2(I) locus of HF32, ranked highest in similarity
in the protein translation frame F of NT735.

However,

the

frame in which the similarity is seen is not the triplehelical coding frame of the a2(I) chain. Many amino acids are
not identical yet show similarity
ments".

as "conservative replace-

All of the human collagens with high nucleotide
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sequence similarity which appeared in the peptide sequence
comparison results showed amino acid similarity in frame D or
F, but few genes were represented in the appropriate triplehelical coding frame. The chick collagens showing similarity
to frame D and F as well.
The Herpes saimiri collagen-like protein mRNA sequence
(Locus:HSVCLS) has 42.5% identity in a 40 amino acid overlap
and 88% similarity when amino acids representing conservative
replacements are included (Figure 17). This similarity is in
the region of
reverse

frame

NT735,
D,

amino acid residues

in which glycine occurs

140-180
at

of the

every sixth

residue. The glycine and tryptophan residues in both sequences
are in homologous positions and the cysteine residues in NT735
are always conservative replacements for

serine residues.

Though this information is interesting its significance is
suspect because the protein translation of HSVCLS with this
similarity is not the actual reading frame of this gene.
However, upon examining the nucleotide sequence of this locus
there is another interesting feature in common with NT735. In
the region of similarity to NT735,

HSVCLS contains an 18

nucleotide repeat which spans its collagen-like open reading
frame (Figure 17b). This repeat has 56% similarity to the 18
nucleotide repeat of NT735.
account

for

the

identity

This similarity is
seen

between

the

likely to
amino

acid

translations discussed above. This is interesting because the
HSVCLS locus is the only other known example (in addition to
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NT735)

of a collagen-like gene containing an 18 nucleotide

basic repeat in its coding region.
Various

loci representing the HMW subunits of Wheat

Glutenin also rank high in amino acid similarity in frames D
thru F. For example, subunits 5 and 10 have as high as 46-57%
identity over lengths of 30-40 amino acids in frames D thru
F. Many of the regions of similarity are in the same consensus
peptide

and

nucleotide

central

sequence

domain

sequences

comparisons

(Table

indicated

in

2).

regions

These

the

reside in a highly repetitive region of the molecule where the
peptide

sequence

predicts

a

secondary

structure

with

an

abundance of a-turns. The cysteine residues located at the
termini of these subunits,

allow the close association of

multiple glutinen monomers by intermolecular disulfide bonding
(Forde et al.
these

I

sequences

residues

is

1985). The a-spiral structure predicted by
and

suggested

the
to

abundance
confer

of

terminal

elasticity to

cysteine
the

wheat

glutinen molecule much like that of human elastin (Tatham et
al., 1984; Venkatachalam et al., 1981).
The above amino acid sequence comparison results are in
agreement with the nucleotide sequence comparison information.
However, due to the technical limitations of the GCG "Tfasta"
program the peptide translations of the genes identified are
often not in the correct coding frame.

This leaves their

relationship to NT735 and a putitive peptide structure or
function ambiguous at best.
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In order to overcome the "Tfasta" routine limitations,
the peptide database Swissprot was also examined using the GCG
routine "Fasta". Each of the reverse frames of the amino acid
translations of NT735 was compared to the swissprot peptide
sequence database.

The results

somewhat different

from those above al though

some common

themes with regard to secondary structure exist.

Nearly every

peptide with

of

these comparisons were

similarity to the NT735

reverse translation

frames was described as a membrane-associated molecule with
a highly hydrophobic transmembrane region (see Table 3). It
is these regions which show the highest similarity to NT735
translations.

These

glycoproteins,
proteins,

and

peptides

surface

antigens

structural

included
and

viral

receptors,

glycoproteins

with

envelope
channel

carbohydrate

attatchment sites. Many of these regions with identity cross
the cell membrane multiple times serving as an anchor for
large intra- and extra- cellular chains with diverse interactive properties. Table 3 summarizes the key features of some
these proteins in an attempt to understand the basic features
of the peptide encoded by NT735. Those listed in the table
have at least 20% identity over a minimum of 20 amino acids,
as has often been reported in other work (Trueb and Trueb,
1992) •

Because the swissprot database search was so informative
with

regard

identified

to

the

consistent

(and of course,

nature

of

the

proteins

in the correct coding frames) ,
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independent protein comparisons were done for both elastin,
mentioned earlier in conjunction with wheat glutinen, and the
HSVCLS protein. No further informative results were obtained
for HSVCLS. However, Swissprot comparisons of NT735 to elastin
proved

informative.

For

a

number

of

species,

including

humans, the range of identity was 39 to 53%, with an overlap
of 17 to 30 amino acids. Although this is not a very long
overlap, a 30 amino acid length is comparable to some of those
proteins listed in Table 3.
Although the specific functional domains of the putative
peptide of NT735 are not yet clear, most of the nucleotide and
amino acid similarities to other protein coding genes lie in
the region of the 18 bp direct repeat. Few matches were seen
in amino acids 200 thru 245 (reverse frames) which represents
the

non-repetitive

Furthermore,

much

portion
of

the

of

the

nucleotide

similarity

identified

sequence.
in

the

"Swissprot" comparisons is to the left of the first Ava II
site (see Figure 3) at nucleotide position 230 (see Figure 8).
Consistent with the initial hybridization studies this site
was identified as the beginning of the helical coding region
for the gene. Although the exact endpoint of the coding region
is still not clear, most of the amino acid similarity appears
confined to the sequence prior to last Pvu II site (nucleotide
position 680). This general pattern is consistent with all my
experimental
presented.

results

and

the

sequence

comparison

data
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Figure 1. Characterization of chromosome 17 phage clones.
A pro-a2 (I) cDNA clone (Hf32) was used to screen a human
chromosome 17 library containing HindIII fragments in lambda
phage Charon 21A.
Five independent positive phage isolates
were digested with HindIII to excise the inserts which were
then hybridized with: A- Pro-a2(I) cDNA (Hf32); B- Pro-al(I)
cDNA (Hf677); c- Alu repetitive sequence (Blur 8). Some
isolates are present in multiple lanes because several
individual plaques from the same original isolate had been
chosen for analysis.
Lane 1 & 2, Isolate #1
Lane 3, Isolate #2
Lane 4, Isolate #3

Lane 5 & 6, Isolate #4
Lane 7 & 8, Isolate #5.

Fragment sizes in kb are indicated.
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Figure 2. Confirmation of successful cloning of target
fragment. DNA from normal placenta (Lanes 1 & 3) and OI Type
III patient blood (Lanes 2 & 4) was digested with HindIII
(Lanes 1 and 2) or PstI (Lanes 3 & 4) and hybridized to the
phage clone (isolate #1). A- hybridization stringency was low
(2xSSC, 50°C). B- stringency was high (O.lxSSC, 65°C).
Selected fragment sizes in kb are indicated.
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Figure 3. Restriction map of the 4.6 kb cloned fragment.
The new collagen locus on chromosome 17 was cloned from a
chromosome specific phage library as a 4.6 kb HindIII
restriction fragment. Restriction sites for the indicated
enzymes are shown on superimposable lines representing the
same HindIII fragment. The locus contains a short triple
helical coding region that cross-hybridizes to the pro-a2(I)
cDNA, Hf32 (black box) . Fragment sizes in base pairs are
indicated. The locations of Alu repetitive sequences are also
indicated(*). Not all restriction sites are shown.
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Figure 4. Restriction mapping of p4.6 and localization of
triple helical coding region.
A- Restriction digests of p4.6 were hybridized to the proa2(I) cDNA probe Hf32.
Lane
Lane
Lane
Lane
Lane

1,
2,
3,
41
5,

HindIII+PstI
HindIII
HindIII+XbaI
EcoRI+PstI
EcoRI+BamHI

Lane 6,
Lane 7,
Lane 8,
Lane 9,
Lane 10,

BamHI
HindIII+Bam HI
HindIII+BamHI+SstI
HindIII+SstI
HindIII+SmaI

Selected fragment sizes in kb are indicated. The fragment
containing triple helical coding sequences is represented by
the 1. 6 kb EcoRI/PstI band seen in lane 4. The strongly
hybridizing 2. 7 kb fragment is the plasmid vector. Lanes
indicated by underlining represent the pertinent data as
discussed in the text.
B- Restriction digests of p4.6 were hybridized to the proa2 (I) cDNA probe Hf32.
Lane
Lane
Lane
Lane
Lane

1,
2,
3,
4,
51

AvaII+BamHI
AvaII+EcoRI
Aval!
AvaII+SstI
AvaII+HindIII

Lane
Lane
Lane
Lane

6, PvuII+HindIII
71 PvuII+PstI
8, PvuII
9, PvuII+SstI

Selected fragment sizes in kb are indicated. Hybridation to
a single (vector) fragment in Lane 6 indicates no hybridization to the upper (1.4 kb) HindIII/AvaII fragment of the
doublet at this position. There is also no hybridization to
an 800 bp PvuII/PstI subfragment of HindIII/ Aval I. These
fragments span the PstI end of the triple helical coding
fragment (see restriction map). Lanes indicated by underlining represent the pertinent data as discussed in the text.
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- 2000

- 750

- 200

Figure 5. Southern blot representing Sau96I restriction
digests of p4.6 hybridized with the pro-a2{I) probe Hf32.
Lane
Lane
Lane
Lane

1,
2,
3,
4,

p4.6 DNA digested with HindIII, EcoRI and Sau96I
pUC13 DNA digested with HindIII, EcoRI and Sau96I
p4.6 DNA digested with EcoRI, PstI and Sau96I
pUC13 DNA digested with EcoRI, PstI and Sau96I

Only vector sequences (pUC13 DNA) in fragments greater than
200 bp are detected by the probe. Fragments representing
insert sequences only are digested by Sau96I into fragments
of less than 200 bp. Sizes in bp are indicated.
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Figure 6. Localization of Alu repetitive sequences in p4.6.
Restriction digests of p4.6 were hybridized to the Alu probe,
Blur 8.
Lane
Lane
Lane
Lane
Lane

1, HindIII+PstI
2 I EcoRI+PstI
3, EcoRI+BamHI
4, BamHI
5, HindIII+BamHI

Lane
Lane
Lane
Lane

6, HindIII+SstI+BamHI
7, HindIII+SmaI
8, EcoRI+SmaI
9, PstI+SmaI

The 1600 bp EcoRI/PstI and the 800 bp HindIII/SstI hybridize
strongly to Blur 8. The 700 bp HindIII/PstI band hybridizes,
although more weakly. Another Southern blot confirmed that
the Alu sequence in the 1600 bp fragment was confined to the
850 bp adjacent to the PstI end of that fragment (data not
shown).
Lanes
indicated by underlining represent the
pertinent data as discussed in the text. Vector sequence
hybridization and larger fragments which were uninformative
are not shown.
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Figure 7. Schematic diagram of the clones and subclones used
to characterize the collagen-like locus. Only a portion of
the vectors are shown in the diagrams. A- The original Charon
21A phage isolate containing the 4.6 kb HindIII insert. Bp4.6, the pUC13 vector containing the 4.6 kb HindIII insert.
c- p4.6EP, the pUC13 vector containing the 1.6 kb EcoRI/PstI
triple helical coding fragment. D- p4. 6ME, the pGEM7Zf+
vector containing the 1.5 kb EcoRI/SmaI triple helical coding
fragment. E- Linearized p4. 6ME and the resulting nested
deletion subclones generated by the "Erase-A-Base" system.
These deleted subclones were recircularized prior to
sequencing. sizes of fragments are indicated in base pairs
(bp).
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1
51
101
151
201
251
301
351
401
451

EcoRI
GAATTCCAGT CACTCCCTCC AGGAGACACA CCAGCAGTGG TCAGGAAGCA
AGTCCACCAC AGCCTTCTGG AAAGGTCTCT AGTCTCAGGA GACACGAGCC
Sau96I
ACTCAAGCCT CCCACATGCC ACCAAAGAAG ATAAGCTGGC CCAGAGAAGA
CCAGCAGCCC AGAGAAGACC AGCAGCCTGG ACAAGACCAA CAGCCCAGAC
Ava II
Aval!
ATAGACCAGC AGCCCAGAAA GGACCAGCAG CCCAGACAGG ACCAGCAGCC
CAGGCAAGAC CAGCAGCCTG GACAAGACCA GCAGCCTGGA
Aval!
AGCCCAGACA TAGACCAGCA GCCCAGACAG GACCAACAGC
Ava II
ACCAGCAGCC CAGACAGGAC CAGCAGCCCA GACAAGACCA
PvuII
CAAGAACAGC TGGCCCAGCA GCCCATACAA GACCAGCAGC

CAAGACCAAC
CCAGACATAG
GCAGCCTGGA
CCAGATATAG

501

CCCAGCAGCC CAGACATAGC CCAGCAGCCC AGACAAGACC AGCAGCCCAG
PvuII
ACAAGACCAG CAGCCTGGAC AAGACCAGCA GCCAGGATAA GAACAGCTGG

551

CCCAGCAGCC CATACAAGAC CAGCAGCCCA GATATAGCCC AGCAGCCCAG

601
651

ACATAGCCCA GCAGCCCAGA CAAGACCAGC AGCCCAGACA AGACCAGCAG
PvuII
CCCGGACAAG ACCAGCAGCC AGGATAAGAA CAGCTGGCCC AGCAGCCCAT

701

ACAAGACCAG CAGCCCAGAC ATAGCCCAGC AGCCC

Figure 8. The complete nucleotide sequence of NT735. Selected
restriction sites are indicated above their recognition
sequence. Numbers on the left margin indicate the nucleotide
position at the start of the line. A space is inserted after
every tenth nucleotide for easier reading.
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Figure 9. 8% Acrylamide sequencing gels. A- An unreadable
sequencing gel generated by the "Sequenase" kit. This
illustrates a typical repeating "ladder" pattern resulting
from premature termination due to GC richness and 2° structure
of the template DNA. This is roughly the same region shown in
B. B- A gel from which 108 nucleotides can be read as
pictured here (position 324 to 432 of the NT735 sequence).
This sequence was generated using the "Ampli-Taq" kit. The
AvaII sites at positions 339 and 366 respectively are
indicated. The letters at the top indicate the nucleotide
represented in the corresponding lane.
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A-

BGATC GTAC

GATCGTAC
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Figure 10. Sequence of NT735 aligned to illustrate the 18
nucleotide direct repeats. There are at least 31 repeats with
a minimum of 83.4% identity to the basic repeat and 3 brief
insertions of 9 nucleotides each. Single thymidine insertions
also occur periodically. The carats indicate the exact
location of the insertions which have been removed and placed
above the sequence that they interrupt. Bold nucleotides
indicate changes from the basic repeat unit. Numbers to the
left indicate the respective repeat. Numbers to the right
indicate the nucleotide position. Selected restriction sites
are indicated.
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GAATTCCAGTCACTCCCTCCAGGAGACACACCAGCAGTGGTCAGGAAGCA
AGTCCACCACAGCCTTCTGGAAAGGTCTCTAGTCTCAGGAGACACGAGCC
ACTCAAGCCTCCCACATGCCACCAAAG
127

~

1

AAGATAAGCGGCCCAGAG

2

AAGACCAGCAGCCCAGAO

3

AAGACCAGCAGCCTGGAC

4

AAGACCAACAGCCCAGAC

5

~GACCAGCAGCCCAGAA

1 8 2

T

7

AVA II
AOGACCAGCAGCCCAGAC
AVA II
AOGACCAGCAGCCCAGGC

8

AAGACCAGCAGCCTOGAC

9

AAGACCAGCAGCCTOGAC

1 0

AAGACCAACAGCCCAGAC

6

2 5 5

3 0 9

..:e.-

1 2

A AG AC CA G CA G CCC AG AC
AVA II
AOGACCAACAGCCCAGAC

1 3

~GACCAGCAGCCCAGAC

1 4

AVA II
AOGACCAGCAGCCCAGAC

1 5

AAGACCAGCAGCCTGGAC

1 1

2 1 9

3 4 6

T

3 8 3

P VU I I

CAGCTOOCC

1 6

AAGA~CAGCAGCCCATAC

1 7

AAGACCAGCAGCCCAGAT

1 8

1 9

~GCCCAGCAGCCCAGAC
~GCCCAGCAGCCCAGAC

2 0

AAGACCAGCAGCCCAGAC

2 1

AAGACCAGCAGCCTOGAC

2 2

AAGACCAGCAGCCAGGAT

2 3

AAGAYCAGCAGCCCATAC

2 4

AAGACCAGCAGCCCAGAT

2 5

A AG CCC AG CA G CCC AG AC

2 6

°l"AGCCCAGCAGCCCAGAC

2 7

AAGACCAGCAGCCCAGAC

2 8

AAGACCAGCAGCCCOGAC

2 9

AAGACCAGCAGCCAGGAT

4 2 8

4 8 4

P VU I I
CAGCTGGCC

5 6 5

..:e.-

6 2 1

6 7 5

P VU I I
CAGCTOOCC

3 0

AAGA~AGCAGCCCATAC

3 1

AAGACCAGCAGCCCAGAC

3 2

AAGCCCAGCAGCCC

.t.

7 3 5

5 0
1 0 0
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A-

148 AGACCAGCAGCCCAGAGAAGACCAGCAGCCTGGACAAGACCAACAGCCCA 197
111111111111
111111111111

II
II

111111111111111111111111111111111
111111111111111111111111111111111

257 AGACCAGCAGCCTGGACAAGACCAGCAGCCTGGACAAGACCAACAGCCCA 306

. *

198 GACATAGACCAGCAGCCCAGAAAGGACCAGCAGCCCAGACA.GGACCAGC 246
111111111111111111111
111111111111111111111

1111111
1111111

11111111111
11111111111

1111111
1111111

307 GACATAGACCAGCAGCCCAGACAGGACCAACAGCCCAGACATAGACCAGC 356
247 AGCCCAGGCA 256-......__
II I I I II
II
/3%
1111111
II
357 AGCCCAGACA 366

---------------------------------B291 AGACCAACAGCCCAGACATAGACCAGCAGCCCAGACA.GGACCAACAGCC 339
1111111111111111
1111111111111111

1111
1111

111111111111111
111111111111111

I
I

Ill
Ill

11111
11111

430 AGACCAGCAGCCCAGATATAGCCCAGCAGCCCAGACATAGCCCAGCAGCC 479
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I

567 AGACCAGCAGCCCAGATATAGCCCAGCAGCCCAGACATAGCCCAGCAGCC 616

340

CAGAC~ACCAGCAGCCCAGACAGGACCAGCAGCCCAGACAAGACCAGC
111111111111111111111111
111111111111111111111111

11111111111
11111111111

391

111111111111
111111111111

480 CAGACAAGACCAGCAGCCCAGACAAGACCAGCAGCCTGGACAAGACCAGC 529
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I

I I I I I I I I I I I I I
I I I I I I I I I I I I I

617 CAGACAAGACCAGCAGCCCAGACAAGACCAGCAGCCCGGACAAGACCAGC 666
PvuII.
392 AGCCTGGACAAGAACAGCTGGCCCAGCAGCCCATACA
I I I I
I I I I

I I I
I I I

I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I I I I I I I I I I I I I I I

429~

./9 2 %------

530 AGCCAGGATAAGAACAGCTGGCCCAGCAGCCCATACA 566~93%
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
"99%-----I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
667 AGCCAGGATAAGAACAGCTGGCCCAGCAGCCCATACA 703~
Figure 11. Higher order repeats of NT735. A- Two 110
nucleotide direct repeats. B- Three 137 nucleotide direct
repeats. Dashed vertical lines indicate nucleotide identity.
Whole
numbers
indicate
nucleotide
position
numbers.
Percentages represent identity between repeats as indicated.
Insertions are indicated by an asterisk (*) in A, or carat
(V) in B. Dots occur every tenth position for easier reading.
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Figure 12. Schematic diagram of the open reading frames of the translated sequence of NT735.
Open boxes indicate the open reading frames. Solid lines represent regions which are not
open reading frames. Letters to the left indicate the frame, with frame A beginning with
nucleotide number 1 and frame F beginning with nucleotide number 735. Numbers on the bottom
indicate nucleotide position.
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Translation frame "F"
1

GLLGYVWAAG LVWAAGPAVL ILAAGLVRAA GLVWAAGLVW AAGLCLGCWA

51

ISGLLVLYGL LGQLFLSWLL VLSRLLVLSG LLVLSGLLGY VWAAGLYLGC

101

WSCMGCWASC SCPGCWSCLG CWSCLGCWSM SGLLVLSGLL VYVWAVGLVQ

151

AAGLVQAAGL AWAAGPVWAA GPFWAAGLCL GCWSCPGCWS SLGCWSSLGQ

201

LIFFGGMWEA *VARVS*D*R PFQKAVVDLL PDHCWCVSWR E*LEF

Translation frame "E"
1

GCWAMSGLLV LYGLLGQLFL SWLLVLSGLL VLSGLLVLSG LLGYVWAAGL

51

YLGCWSCMGC WASCSYPGCW SCPGCWSCLG CWSCLGCWAM SGLLGYIWAA

101

GLVWAAGPAV LVQAAGLVWA AGPVWAAGLC LGCWSCLGCW SMSGLLVLSR

151

LLVLSRLLVL PGLLVLSGLL VLSGLLVYVW AVGLVQAAGL LWAAGLLWAS

201

LSSLVACGRL EWLVSPETRD LSRRLWWTCF LTTAGVSPGG SOWN

Translation frame "D"
1

AAGLCLGCWS CMGCWASCSY PGCWSCPGCW SCLGCWSCLG CWAMSGLLGY

51

IWAAGLVWAA GPAVLILAAG LVQAAGLVWA AGLVWAAGLC LGCWAISGLL

101

VLYGLLGQLF LSRLLVLSGL LVLSGLLVYV WAVGPVWAAG LCLGCWSCPG

151

CWSCPGCWSC LGCWSCLGCW SFLGCWSMSG LLVLSRLLVF SGLLVFSGPA

201

YLLWWHVGGL SGSCLLRLET FPEGCGGLAS *PLLVCLLEG VTGI

Figure 13. Amino acid sequence translations of
frames of NT7 3 5. A space is inserted after
residue to facilitate readability. Some glycine
highlighted in bold in order to demonstrate
interval pattern in which they occur. Asterisks
the presence of a "stop" codon.

the reverse
every tenth
residues are
the regular
{*) indicate

76

Figure 14. Codon preference data for reverse translation
frames of NT735 (D, E and F). The letters on the left
indicate the reading frame represented by the corresponding
graph. The numbers on the top and bottom of the figure
indicate approximate nucleotide positions. The solid line
represents codon preference. The dashed line represents GC
bias. The Y-axis is split in three sections. A curve lying in
the upper region (1. 2-2. 0) indicates a strong pattern of
codon choices similar to that of expressed genes. One lying
in the lower region indicates no pattern of similarity to
expressed genes (0-0. 75). The middle region represents a
pattern which cannot be accurately assessed based on the
information available. Nearly all codon preference curve lies
in the upper third of the graph. Much of the GC bias curve
lies in the upper two-thirds of the graph; sometimes in the
upper third coinciding with codon preference in select
regions of the sequence. This data indicates that the coding
sequence in the reverse frames is likely to contain pref erred
codons which occur in genes which are expressed. The boxes
beneath each graph correspond to the open reading frame and
the small vertical ticks below them represent the occurance
of a "rare" codon relative to the frequency of the codons for
that frame.
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NT735 x Humcoll
DEFINITION: Human collagen pro-a2(I) chain mRNA.
Percent Identity:

67.320

Length:

175

Gaps: 4

395 GCTGCTGGTCTTGTCTGGGCTGCTGGTCCTGTCTGGGCTGCTGGT ••••. 351
I I I
I I I

I I I I
I I I I

I I I
I I I

I
I

I I
I I

I I I I I I I I I
I I I I I I I I I

I
I

I I
I I

I
I

I I I
I I I

164 GCTCATGGTGCTGTAGGTGCCCCTGGTCCTGCTGGAGCCACAGGTGACCG 213

350 ... CTATGTCTGGGCTGTTGGTCCTGTCTGGGCTGCTGGTCTATGTCTGG 304
I
I

I
I

I
I

111111
I I I I I I

11111111
I I I I I I I I

I
I

111111111
I I I II I I I I

II
II

II
I I

214 GGGCGAAGCTGGGGCTGCTGGTCCTGCTGGTCCTGCTGGTC ..• CTCGGG 260

303 G•.... CTGTTGGTCTTGTCCAGG •...•• CTGCTGGTCTTGTCCAGGCT 265
I
I

I I I
I II

I I
I I

I
I

I I
I I

I
I

I I I
I I I

I I II I I I
I I I I I I I

I
I

I
I

I
I

261 GAAGCCCTGGTGAACGTGGCGAGGTCGGTCCTGCTGGCCCCAACGGATTT 310

264 GCTGGTCTTGCCTGGGCTGCTGGTC 240
I I I I I I I
II I I I I I

I I
I I

I
I

I I I I I I I I I I
I I I I I I I I I I

311 GCTGGTCCGGCTGGTGCTGCTGGTC 335

Figure 15. GCG "bestfit" comparisons of NT735 (top) to the
Hf32 (bottom) region of HUMCOLL locus. Dashed vertical lines
indicate
nucleotide
identity.
Whole
numbers
indicate
nucleotide position. Dots are placed at every tenth position
above the sequence.
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NT7315 z Humcglpal
DEFINITION: Human pro-al(I) chain of type I collagen mRNA.
Percent Identity: 64.151

342

Length: 122

Gaps: 3

GGGCTGTTGGTCCTGTCTGGGCTGCTGGTCTATGTCTGGGCTGTTGGTCT 293
I
I

I I I
I I I

• I I I I
• I I I I

I I
I I

•
•

I
I

I I
I I

I I I I
I I I I

I
I

I
I

I I I I I
I I I I I

I
I

1865 GTGCTCNTGGTGCTCNTGGTGCCCCTGGCC •••.....•• CCGTTGGCCC 1904

292

TGT .•. CCAGGCTGCTGGTCTTGTCCAGGCTGCTGGTCTTGCCTGGGCTG 246
I I
I I

I
I

I I
I I

I I
I I

I I
I I

I I
I I

I I
I I

I I
I I

I I I I I I
I I I I I I

I I I
I I I

I
I

I
I

I
I

1905TGCTGGCAAGAGTGGTGATCGTGGTGAG ... ACTGGTCCTGCTGGTCCCG1951

245 CTGGTCCTGTCTGGGCTGCTGG 224
I
I

I I I I I
I I I I I

I I I
I I I

I
I

I
I

I I I I I
I I I I I

1952 CCGGTCCCGTCGGCCCCGCTGG 1973

Figure 16. GCG "bestfit" comparison between NT735 (top) and
Hf677 region of Humcglpal locus. Dashed vertical lines
indicate
nucleotide
identity.
Whole
numbers
indicate
nucleotide position. Dots are placed at every tenth position
above the sequence.
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ADEFINITION Herpesvirus saimiri collagen-like protein
ACCESSION M3 l 964
KEYWORDS collagen-like protein
42.5% identity in 40 aa overlap
88% similarity over 40 aa overlap

120
130
140
150
160
Nt735dLLVLSGLLVLSGLLVYVWAVGPVWAAGLCLGCWSCPGCWSCPGCWSCLGCWSC
1 • • • 11.1 ••
1••
•11•1••

1.1 ••
, . , ••

1.1 •• 11.1 ••
1•1••11•1••

HsvclsXNYDSKQXVCYKQSWQSXRSWRSWGSWRSLGSWRSLGSWRSLGSWRSLGSWRS
440
450
460
470
480
170
180
190
200
Nt735dLGCWSFLGCWSMSGLLVLSRLLVFSGLLVFSGPAYLLWWHVGGLSGSCLLRLE
I I • I •
I I • I •

I I • I
I I • I

HsvclsLGSWRSLGSWRSWRSLRSSISCFFSWISXVWLACHFLSSVFVLLLLAVSCVTL
490
500
510
520
530

BNT735
HSVCLS

ACAAGACCAGCAGCCCAG
I
I

1111
1111

I
I

1111
1111

GGACCTCCAGGACCCCAA

Figure 17. Sequence comparisons between NT735 and the
collagen-like sequences of H. saimiri virus. A- Amino acid
sequence comparison results from the GCG "Tfasta" subroutine.
Dashed vertical lines (I) indicate identity. Double dot
vertical lines (:) indicate that the residues have similarity
as conservative replacements. Whole numbers indicate amino
acid position. B- Nucleotide sequence comparison between the

18

nucleotide

repeats

of

NT735

and

H.

saimiri.

Dashed

vertical lines Cl) indicate identity. The two repeats have
56% identity.
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ANC3

/
COL2
GAG

NC2

NC1

+

+

COL1

..
50 nm

B-

Type IX

1'11

1

i I I I

Type II
fibril

Figure 18. Schematic diagrams of the domains of the Type IX
collagen molecule (A) and its alignment on the surface of the
Type II fibril in cartilage (B) . At the hinge region the COL3
and NC4 domains project into the matrix, while the GAG side
chain associates in the gap region of the fibril. Reproduced
from Biomaterials Vol. 11, p. 30 (van der Rest et al., 1990).
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Table 1. Collagen genes with nucleotide similarity to NT735.
This table summarizes those collagen genes identified with
the GCG fasta program having 50% or greater similarity to
NT735. Genes with less than a 100 nucleotide overlap are not
included. The column labelled "Strand" indicates whether the
similarity is in the forward {/for) or reverse {/rev) strand
of NT735. In the "GAPS" column an asterisk {*) indicates a
"fasta" comparison result, therefore no significant gaps are
present.
Fasta comparisons optimize the length of overlap
and minimize gaps to only a few nucleotides, whereas
"bestfit" comparisons optimize identity by finding that
portion of the sequence with highest identity {forfeiting
overlap length and inserting gaps). When two bestfit
identities are reported for the same gene, they represent the
same region of comparison with a different number of gaps
allowed.

CENE TYPE

Human
Collagens

Other couagens

LOCUS

STRAND

%IDENTITY

OVERLAP
(bp)

CAPS

DESCRIPTION

HUM COLL

/rev

67.32
52.0

175
690

LI

a2(1) Collagen LOCUS
Of Hf32

HUMCG1PA1

/rev

6Ll.15
52.5

122
621

.
.
3

a1 (I) Collagen LOCUS
Of Hf677

HUMCOL16A

/for

67.6
7Ll.6

179
97

6
3

a11XVll collagen
Bone FACITS

CELCOL

/for

5LI
63

550
16LI

LI

c. Elegans cuticle
collagen

CHKCOL

/rev

5LI

Ll02

.
.

XELCOL2A1

/rev

53

5Ll9

•

Chicken a2m collagen

X. Laevls a1UO
collagen

DROCOL

/for

59
56

131
308

.
1

Drosophila cuticle or
B.M. collagen gene

CHKCOL 1LIA1

/for

5LI

387

•

Chicken a11XIV) FACITS
collagen

Type x collagen

/for

50·60

100·200

n/a

Multiple Species

Type IX collagen

/for

50·60

100·300

n/a

Multiple Species

00

w
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Table 2. Non-collagen genes with nucleotide similarity to
NT735. This table summarizes the nucleotide sequence comparison results for those non-collagen loci with high sequence
similarity over long (>200 nt) stretches. The column labelled
"STRAND" indicates whether the similarity is in the forward
(/for) or reverse (/rev) strand of NT735. In the "gap" column
an asterick (*) indicates a "fasta" comparison result,
therefore no significant gaps are present. Fasta comparisons
optimize the length of overlap and minimize gaps to only a
few nucleotides, whereas "bestfit" comparisons optimize
identity by finding that portion of the sequence with highest
identity (forfeiting overlap length and inserting gaps). The
column labelled "OPA" indicates if the gene does (Y=Yes) or
does not (N=No) contain OPA repeats.

GENE

LOCUS

STRAND

%ID

OVERLAP

CAPS

DESCRIPTION

OPA

Wheat
Glutinen

WHTGL1018

/for

66.6
60

639
557

12
4

Wheat eQuivalent
of Elastin

N

Human
Elastin

HSELASRNA

/rev

54.8
63.2

345
134

*
1

Human elastin gene
-Hydrophobic exon

N

OroSOQhila
Mastermind

ORO MAS

/for

67.7

196

4

OPA repeat of
o.virilis Mastermind
gene

y

Mouse OPA

MUSOPA

/for

60.9

417

*

OPA repeat of
M.musculis

y

orosoQhila
Prospero

DROP ROS

/for

60

225

*

Large, nuclear,
DNA binding
protein of
o.melanogaster

y

DrosOQhila FSH

DROFSH

/for

53.7

566

*

o.melanogaster
homeotic gene
-Membrane prot.

y

OroSOQhila
Elav

DROELAVG

/for

59.2

255

*

o.virilis possible
RNA binding
protein

N

0)

01
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Table 3. Summary of proteins with similarity to the NT735
reverse translations. Comparisons were done using the
"Swissprot" database. The region of similarity in the peptide
translation of NT735 is indicated by frame and amino acid
position. comments regarding structural features of the
identified proteins are limited to the regions with identity.

Region Of slmllartty
within NT7:S5 translation
<amino acid position>

FRAME

Latent membrane protein of
Epstein-Barr virus

10-40

E

Transmembrane region
-Hydrophobic
Viral membrane protein
-Leuclne rich

Kell G-proteln

25-45

E

corresponds to exact
transmembrane region <30-45> of Kell
-same as In VGLM

Uukunleml virus membrane
glycoprotelns G1 and G2

30-95

D

A.K.A. VGLM
Viral llpo-membrane region adjacent
to G2
-Hydrophobic

Rat heart Na+ channel lsoform

40-80

D

Transmembrane region of Na+
channel

Chicken Elastln

150-180

F

Collagen-like nature
-Hydrophobic region

Hepatitis c virus <HCV> envelope
protein

135-185

E

Clustered glycosvlatlon sites
-Hydrophobic

X.laevls cystic fibrosis

175-215

E

overlaps two transmembrane
regions and spans Junction

Latent membrane protein of
Epstein Barr virus

66-208

D

Spans membrane five times!
<25% ID, 52% Slmllarltv>

woodchuck Hepatitis virus
Surface Antigen

100-210

D

Nearly entire Surface Ag chain!
<23% ID, 57% Slmllarltv>

PROTEIN

tranductance regulator

PROTEIN FUTURES

Large regions of overlap:

00

-..J

DISCUSSION

This work involves the isolation and characterization of
a new human collagen-like locus associated with osteogenesis
imperfecta.
fragment,
1991) .

The

locus,

represented

by

is located on chromosome 17

a

4. 6

kb

HindIII

(Cammarata et al. ,

The goal in this study was to isolate the 4. 6 kb

HindIII fragment and characterize the triple helical coding
region within it. Restriction mapping and sequencing was the
approach

chosen

as

a

first

step

to

understanding

what

molecular organization might contribute to the deletions seen
in

OI

patients

at

this

site.

Determining

the

detailed

molecular organization of this locus is also the necessary
initial step in characterizing the structure, and ultimately
the function, of the putative protein for which the new locus
codes.

Identification of Cloned Seguences
The initial hybridization studies (Figure 1) confirmed
that sequences within this locus have similarity to triple
helical coding regions of the COL1A2 gene. These sequences
are

distinct

from

those

of

the

COLlAl

gene,

which also

resides on chromosome 17. Since there are no other reported
88

89
collagen genes on chromosome 17
clearly

contains

sequences

(Byers,

of

a

1989), this locus

new human

collagen-like

locus. These studies also demonstrate that the clone, p4.6,
is more similar to helical coding sequences of COL1A2, than
COLlAl. This information was later confirmed through direct
sequence analysis.
Hybridization of the clone back to human genomic DNA
confirmed

that

this

locus

does,

in

fact,

represent

the

deletion-prone fragment previously shown to be associated
with the OI phenotype (Figure 2).

Repeat Organization and Deletion Mechanisms
Although

the

presence

of

Alu

direct

repeat

sequences is not unusual in collagen genes
1981;

Chu et

al.,

1984;

Sandell

family

(Barsh et al.,

and Boyd,

1990),

their

exceptionally high density in regions adjacent to the helical
coding

sequences

of

this

new

locus

is

noteworthy.

Many

instances have been described where Alu-Alu recombination has
caused clinical pathologies due to the deletion of coding
information (Lehrman et al., 1987, Markert et al., 1988). The
evolutionary
homologous
suggested

divergence

recombination
(Kudo

et

al.,

of

two

related

genes

at

Alu

repeats

has

1989).

Both

intra-

due

also
and

to
been

inter-

chromosomal unequal recombination and interchromatid unequal
recombination

have

been

suggested

to

contribute

to

polymorphisms seen at Alu sites (Vnencak-Jones et al., 1988).
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Repetitive sequences with relatively short basic repeat
units

(2-25

nucleotides)

deletions which
reports

of

a

lead to

region

can

also

be

responsible

length polymorphisms.

adjacent

to

the

COL2Al

for

There are
gene

which

exhibits a high degree of length polymorphism due to the
variation

in the number

of copies of

repeating dinucleotide sequence.
are

adjacent

to

polymorphisms

via

COL2Al
a

a

simple tandemly

The tandem repeats which

are

mechanism

suggested

to

known

"slipped-strand

as

cause

the

mispairing" (Tiller et al., 1990; Sykes et al., 1985; Stoker
et al., 1985).
and

excision

such a mechanism can cause the looping out
of

intervening

DNA when

one direct

misaligns with another during DNA replication.
al., 1992; Efstratiadis et al., 1980).

repeat

(Richards et

This same event also

occurs in some cases of Alu-Alu recombination except that the
Alu

repeats

intervening

reside
or

in

excised

the

introns

coding

DNA

of
does

a

gene

not

and

the

necessarily

contain a directly repeating motif (Lehrman et al., 1987).
The organization of the 18 nucleotide tandem repeat of
NT735 is much like that of the direct repeats which cause
polymorphisms seen in other collagen and non-collagen genes
(Stoker et al., 1985; Richards et al., 1992; Zuliani et al.,
1990). Since there is high identity between the repeats of
NT735,

and

they

extend

for

at

least

600

base

pairs,

misalignment during DNA replication not only seems possible,
but highly probable. It is therefore likely that this direct
repeat organization is the cause of the length variations
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seen at the Site 2 locus.
Recent studies in our lab have,

in fact,

mapped the

deletion site in an OI Type III patient to the EcoRI/PvuII
restriction fragment in the sequenced region containing the
direct

repeats

(Michaels,

unpublished).

Future

studies

analyzing the molecular structure of this region in affected
individuals will clarify the endpoints of those deletions
which

are,

in

fact,

associated

with

the

Type

III

OI

phenotype.
Although the possibility may exist, the information obtained
to this point is not consistent with the involvement of the
Alu repeats as a cause of the deletions at this site.
The detection of 4.6 kb and 4.3 kb alleles of a normal
individual,

in

addition

to

the

single

4.4

kb

deletion

fragment of a homozygous, CI-affected individual (Figure 2)
indicates that not all deletions at Site 2 result in an
obvious

OI

phenotype.

It

is

possible

that

individuals

heterozygous for small deletions may be less affected, if at
all, than individuals who are either heterozygous for larger
deletions or homozygous for deletions at this locus.

The

specific location and/or extent of the deletion within Site
2

could

also

play

a

role

in

the

mispairing

can

expression

of

the

OI

phenotype.
Slipped-strand
duplication

or

amplification

of

also

repeated

result

in

the

sequences.

The

amplification of direct repeats has been associated with
other heritable disorders such as fragile X syndrome and
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myotonic dystrophy (Caskey et al., 1992). In these disorders
premutation alleles contain triplet-repeat sequences which,
when amplified beyond a crucial threshold number, result in
events that cause the expression of the disease (Caskey et
al.,

1992). Due to the same molecular mechanism (slipped-

strand mispairing),
in

these

the sequence amplification that results

pathologies

is

the

direct

complement

to

the

deletion-caused condition in p4.6 associated with Type III
OI.

Not only can the slipped-strand mispairing mechanism
contribute to detrimental events resulting from duplication
or deletion but it can also serve a function in the evolution
of

repetitive

sequence

families

and

gene

families

which

contain repetitive motifs (Levinson and Gutman, 1987; Kudo et
al., 1989; Saitta et al., 1991). The structure of the higher
order

repeats

in NT735

suggests

that

tandem duplication

events are likely the mode of evolution in this gene.

The

nature of those duplications can be assessed by examining the
relationship

between

similar

repeats.

Generally,

those

repeats with higher identity to each other are more closely
related and more recently amplified than their counterparts
of lesser identity (Carnahan et al., 1993). For example, in
Figure llb,

the 137 nucleotide higher order repeats which

occur at a location represented by nucleotide positions 291429 and 430-566 have 92% identity, whereas the later repeats,
positions 430-566 and 567-703 have 99% identity. This repeat
organization indicates that the last two repeats, with 99%

93
identity, are more recently amplified than repeats earlier in
the sequence.
between

Thus,

repeats,

sequences
identity),

is

the

from

to

based on the extent of the identity
likely evolutionary order

the

the

18

more

nt

repeats

recent

110

of

these

(approximately
nt

(93%

84%

identity)

intermediate. Finally, the 137 nt repeats with the highest
identity (99%) must be most recently evolved.

An Expressed Collagen-Like Gene
From the hybridizations (Figures 1 and 4) and nucleotide
sequence translations (Figure 13) it is clear that the Site
2 locus contains a collagen-like sequence with a repetitive
motif.

The level of GC richness

(60%)

seen in the NT735

sequence is similar to that of other collagen and connective
tissue

(ECM)

genes.

Analysis

of

potential

open

reading

frames,

codon preference, and GC bias (Figures 12 and 14)

suggests that the reverse translation frames contain coding
information likely to occur in a gene that is expressed.
Recently, Northern blot and dot blot hybridizations of total
RNA from normal human fibroblasts to p4. 6 sequences confirmed
that

this

locus

unpublished) •

is,

Future

in

studies

fact,
will

transcribed
determine

the

(Breslin,
correct

reading frame and the exact regions that are transcribed.
Abnormal Type I collagen incorporated into fibrils has
a drastic effect on tissue integrity, resulting in the OI
phenotype (Prockop et al., 1989). Since the Site 2 collagenlike gene is associated with the OI phenotype (Doering et
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al., 1987), it is likely that defects in its protein product,
which

result

from

misalignment

contribute to the OI phenotype.

and

deletion,

will

also

Because the exact structure

of the protein product has not yet been identified, it is
difficult to say specifically how these deletions affect its
structure.

Possible Gene Families and Protein Product
The

lack

of

"pure"

triple

helical

coding

sequence

(Figure 13), along with similarity to collagen genes with
exons larger than the 54 bp primordial unit,

and a

high

similarity to sequences of the FACITs Types IX, XIV and XVI
(Table 1) ,
f ibrillar

all indicate that this gene may encode a nonor

Imperfections

fibril-associated
in

the

triplet

{FACITs)

pattern

of

molecule.

non-f ibrillar

collagens are often the result of a missing glycine so that
the

amino

acid

imperfections
{Gordon

et

sequence

are
al.,

seen
1991).

is

GLY-X-Y-X-Y.

in many
Such

of

the

These
FACITs

imperfections

sorts

of

collagens

afford

the

otherwise rigid protein more flexibility at that site. Also
characterized by triplet sequence interruptions,

the non-

collagenous {NC) domains of the FACITs often contain few, if
any, glycine residues. The pattern in the Site 2 collagen
gene is also an interrupted triplet sequence which contains
a substitution for a glycine rather than a missing glycine so
that the amino acid sequence (in some regions) is Gly-X-Y-ZX-Y (see Figure 13). This pattern also suggests that this
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molecule

has

the

potential

for

flexibility

while

still

maintaining a collagen-like a-helical structure.
The nucleotide similarity between NT735 and all three of
the Type IX genes is in the region coding for the COL3 domain
of the Type IX molecule {Table 1) . This region is adjacent to
the

"flexible

hinge"

which

allows

this

domain

and

the

globular NC4 domain to protrude into the perif ibrillar matrix
{Figure 18). This flexibility imparts a unique, interactive
capacity to the Type IX collagen molecule. The arrangement is
ideal if the NC4 and GAG domains

{see Figure 18)

are to

facilitate an interactive function with other cellular or
extracellular matrix components. Although COL3 is collagenous
in nature,

it does not align in parallel with the Type I

fibril. Thus, though a somewhat rigid extension is needed in
order to project the NC4 domain into the matrix, a strict
triple helix is

less crucial,

and perhaps

impracticable, in this kind of region.

in some cases

The structure of the

putative protein coded by p4.6 may serve a similar function,
since

it

too

has

the

potential

flexibility

of

Type

IX

collagen, while maintaining a somewhat rigid form.
Also adjacent to the COL3 domain of Type IX collagen, at
the site of the hinge, is the GAG side chain attachment site
{see

Figure

18).

This

is

the

domain

that

imparts

the

proteoglycan characteristic and function to the otherwise
collagenous

nature

of

the Type

IX molecule.

It

is

this

molecular architecture that makes the COL3 domain a bridge
between the interactive components of the Type IX molecule.
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It is possible that the same kind of region in p4.6 may serve
a similar function.
The NT735 translation (reverse frames)

indicate other

features in common with Type IX collagen and other FACITs,
such as a high serine and leucine content and the abundance
of

cysteine

residues

(Ninomiya

et

al.,

1990).

Cysteine

residues allow inter- and intra-molecular crosslinking of the
collagen polypeptide and are important in determining the
structure of the terminal globular domains of the Type IX
molecules

(Ninomiya et al.,

1985). The abundance of these

residues suggests that the p4.6 gene product has the capacity
for forming other higher order structures in addition to a
typical a-helix.
In addition to its common features with the collagens
and their genes, the high sequence identity of NT735 to the
elastin-like wheat glutinen genes
possibility

that

contributes

tissue

NT735

codes

strength

(Table 2),

for

through

suggests the

an

ECM

gene

an

elastic

which

type

of

flexibility. The sequence identity to human elastin (Table 2)
supports this conclusion. The human elastin gene, like p4.6,
contains

high

numbers

of

glycine

and

other

hydrophobic

residues as well as an abundance of Alu repetitive sequences
(Indik et al,
NT735

1990). Two elastin exons with similarity to

code for

very hydrophobic

regions

of the molecule

(Tatham et al., 1984). This agrees with codon frequency data
indicating that NT735 codes a highly hydrophobic peptide.
Amino acid sequence comparisons using the "Swissprot"
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database indicate a nearly exclusive similarity of the NT735
translation

{reverse

frames)

with

proteins

containing

hydrophobic transmembrane domains

{Table 3). Much of this

identity

glycoproteins

is with viral

envelope

and

other

transmembrane or cell/viral surface proteins. For example,
there are long stretches of similarity to Hepatitis

c virus

envelope

surface

glycoprotein,

Woodchuck

hepatitis

virus

antigen, latent membrane protein of Epstein-Barr virus, and
a

shorter

stretch

of

the

Uukuniemi

virus

transmembrane

portion of the G1 and G2 membrane glycoproteins. There are
also multiple stretches of similarity to other transmembrane
or membrane associated proteins such as the sodium channel of
the

rat

heart

{Cine),

conductance regulator of
the human CF

the
~

cystic

fibrosis

transmembrane

laevis, which has 77% identity to

gene, and the surface exposed human Kell blood

group glycoprotein.
Most

of

these

proteins

are

membrane-associated

glycoproteins containing hydrophobic, a-helical transmembrane
regions rich in the nonpolar amino acids Gly, Ala, Leu, Ilu,
Val and Arg; the same features identified in the the putative
peptide of NT735. Some are involved in membrane transport,
for

example,

Na+

transport

system

and

the

CFTR

channel

activity {Rogart et al., 1989; Tucker et al., 1992). Others
are viral

envelope glycoproteins with effector functions

(Moorthy et al., 1990, Kato et al., 1990; Kato et al., 1991),
and

yet

others

are

transmembrane

glycoproteins

with

a
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structural and/or

interactive role

in matrix association

(Ronnholm and Petterson, 1987).
Many
molecules

transmembrane
also

glycoproteins

containing

cytoplasmic

are
and

multidomain
extracellular

extensions with various functions (Nicholls, 1978). Other ECM
associated

receptor

molecules

have

been

described

which

contain such an architecture. For example, the ECM-associated
membrane glycoproteins Syndecan and CD44 are ligand binding
molecules

which

contain

large

interactive

extracellular

extensions anchored by an a-helical transmembrane domain
which crosses the cell membrane multiple times (Sandell and
Boyd,

1990). A short cytoplasmic domain may additionally

associate

intracellularly with the cytoskeleton.

Both of

these molecules are able to bind the intersitial collagens as
well as other smaller ECM molecules (Jalkanen et al., 1991).
The above sequence comparisons have
similarity

of

characteristics

the
to

NT735
a

sequence

number

of

and
ECM

identified high
its

structural

components

and

transmembrane glycoproteins, which are important in directing
the composition and structure of the extracellular matrix and
effecting cellular interaction with the matrix (Alberts et
al., 1989). This supports a function in which the putative
protein

encoded

by

the

interaction of Type I
acting as a
Olsen,

p4.6

locus

could

modulate

the

collagen fibrils with the cell by

communication bridge between them

(Shaw and

1991; Gordon et al., 1989). This is possible via a

signaling

function

which

directs

the

secretion

of

ECM
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components or in a structural capacity, somehow connecting or
associating the major fibril with other cell-secreted ECM
components

(Vaughan

et

al,

1988;

Muller-Glauser et

al.,

1986).
If the p4.6 gene product does modulate Type I
interactions,

then

strength

structural

and

it

has

the

potential

integrity

of

to

Type

fibril

affect
I

the

collagen-

containing tissue. Thus, defects in p4.6 which disrupt this
interactive capacity, could in turn effect the expression of
the OI phenotype where either a Type I collagen defect is or
is not present. For example, there are many cases described
where substitutions for glycine in similar positions of the
same polypeptide chain can produce drastic differences in
severity between individuals. It is possible that a second
mutation, which modulates the effect of a Type I collagen
mutation, could cause a more severe condition, such as that
seen in Type III OI. Alternatively, a single defect at this
new collagen-like locus, could itself result in the Type III
OI phenotype.
RFLPs that are linked to the Type I procollagen genes
have been shown to segregate with many of the autosomal
dominant forms of OI (Sykes et al., 1990; Superti-Furga et
al.,

1989).

However,

the

fact

that multiple

individuals

carrying the same Type I collagen defect exhibit substantial
variability in the severity of their OI clinical symptoms,
even being asymptomatic, complicates diagnosis and genetic
counseling. This situation can be greatly improved by the
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detailed knowledge of other connective tissue genes, such as
the p4.6 locus, that might modulate the OI phenotype.
Sequencing of this "normal" p4. 6 allele provides the
basis for examining the structure of deleted alleles in the
normal population in comparison to those of asymptomatic
parents

and

their

affected

offspring.

This

sequence

information will permit pinpointing the specific deletion
boundaries in OI patients which may suggest the molecular
basis for the deletions. Ultimately, further characterization
of

this

locus

might

permit

its

use

as

a

marker

for

individuals predisposed to having a Type III OI child.
Determining the detailed molecular organization of this
\

locus

has

also

been

the

necessary

initial

step

in

characterizing the structure, and ultimately the function, of
the putative protein ( s)
Whatever

its

product,

collagen,

a

related

for

which

whether
ECM

it

the
be

protein,

new
a

or

locus

true
a

codes.

structural

transmembrane

glycoprotein with extracellular extensions that influences
matrix assembly,
previous

studies

demonstrate

that

this
of

new

locus

OI

patients

deletions

associated with the disease.

at

is

this

of
and

importance
their

locus

are

since

families
clearly
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